ABCG5/G8 — гетеродимер переносчика АТФ-связывающей кассеты ABCG5 и ABCG8 (The heterodimer of ATP-binding cassette transporter ABCG5 and ABCG8)
AC — до еды (при назначениях) — ante cibum
АСЕР — Американская коллегия врачей неотложной помощи (American College of Emergency Physicians)
ACOG — Американская коллегия акушеров и гинекологов (American College of Obstetricians and Gynecologists)
AHA — Американская кардиологическая ассоциация (American Heart Association)
ALTE — очевидное опасное для жизни событие (apparent life-threatening event)
APLS — курсы расширенных реанимационных мероприятий в педиатрии, спонсируемые Американской академией педиатрии и Американской коллегией врачей неотложной помощи (Advanced Pediatric Life Support)
AVPU — шкала для оценки уровня сознания («в ясном сознании»; «реакция на вербальные раздражители»; «реакция на боль»; «без сознания») (alert, verbal, pain, unresponsive)
BRUE — быстро разрешившиеся необъяснимые события (Brief resolved unexplained events)
BSEP — насос выведения солей желчных кислот
CADASIL — церебральная аутосомно-доминантная артериопатия с подкорковыми инфарктами и лейкоэнцефалопатией (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)
NICE — Национальный институт здоровья и клинического совершенствования (качества медицинской помощи) Великобритании (National Institute for Health and Clinical Excellence)
NK — естественные клетки-киллеры (natural killer)
NMDA — N-метил-D-аспартат (N-methyl-D-aspartate)
NMDA — N-метил-D-аспартатные рецепторы
NNT — число больных, которых необходимо пролечить, чтобы достичь какого-то указанного эффекта (Number Need to Treatment)
OR — отношение шансов (odds ratio)
paCO2 — парциальное давление углекислого газа в артериальной крови
PALS — курсы расширенных реанимационных мероприятий в педиатрии (Pediatric Advanced Life Support)
PANDAS — аутоиммунное нейропсихиатрическое расстройство в детском возрасте, ассоциированное со стрептококковой инфекцией (Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection)
PANS — острый нейропсихиатрический синдром в детском возрасте (Pediatric acute-onset neuropsychiatric syndrome)
paO2 — парциальное давление кислорода в артериальной крови
PAS — фуксинсернистая кислота, реактив Шиффа (periodic acid-Shiff)
PC — после еды (при назначениях) — post cibum рСO2 — парциальное давление углекислого газа
PCSK-9 — пропротеиновая конвертаза субтилизин-кекси-нового типа 9 (proprotein convertase subtilisin/ kexin type 9)
PFAPA — периодическая лихорадка с афтозным стоматитом, фарингитом и лимфаденитом (Periodic Fevers with Aphthous stomatitis, Pharyngitis and Adenitis)
PIM — показатель летального исхода у детей (Pediatric Index of Mortality)
piO2 — парциальное давление кислорода во вдыхаемом
воздухе
рO2 — парциальное давление кислорода
POLG — субъединица ДНК-полимеразы у
PRISA II — оценка риска госпитализации у детей II (Pediatric Risk of Admission)
PRISM — риск летального исхода у детей (Pediatric Risk of Mortality)
PRN — при (по) необходимости (Pro re nata — при возникновении обстоятельств)
PRSS — ген сериновой протеазы
PS. — примечание (Post scriptum)
PUVA-терапия — псорален-ультрафиолет А-терапия (psoralen and ultraviolet А)
Q#H — каждые # часов (при назначениях) — quaque ... hora
QAM — каждое утро (при назначениях) — quaque ante meridiem
QPM — каждый вечер (при назначениях) — quaque post meridiem
RAG — ген, активирующий рекомбиназу
RePEAT— пересмотренный инструмент для оценки педиатрической неотложной медицинской помощи (Revised Pediatric Emergency Assessment Tool)
RF — ревматоидный фактор
Rh — резус(-фактор)
Rh«-» — резус-отрицательн(ый)
Rh«+» — резус-положительн(ый)
ROHHAD — быстро развивающееся ожирение с дисфункцией гипоталамуса, гиповентиляцией и спонтанной дисрегуляцией (rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation)
RR — относительный риск (relative risk или risk ratio) RW — реакция Вассермана (reaction of Wassermann)
SaO2 — сатурация артериальной крови кислородом SatO2 — насыщение крови кислородом
ScvO2 — насыщение кислородом центральной венозной крови (Central venous oxygen saturation)
aDG-RD — дистрофии, связанные с a-дистрогликанами (alpha dystroglycan-related dystrophies)
β-ХГЧ — β-субъединица хорионического гонадотропина человека
В ходе подготовки статей по неонатологии в педиатрии для пользователей сайта МедУнивер использованы труды следующих авторов:
Andrews B, Myers P, Lagatta J, Meadow W: A comparison of prenatal and postnatal models to predict outcomes at the border of viability, J Pediatr 173:96-100, 2016.
Braveman PA, Heck K, Egerter S, et al: The role of socioeconomic factors in black-white disparities in preterm birth, Am J Public Health 105(4):694-702, 2015.
Callaghan WM, MacDorman MF, Rasmussen SA, et al: The contribution of preterm birth to infant mortality rates in the United States, Pediatrics 118(4):1566-1573, 2006.
Carnaghan H, Baud D, Lapidus-Krol E, et al: Effect of gestational age at birth on neonatal outcomes in gastroschisis, J Pediatr Surg 51(5):734-738, 2016.
Costello JM, Polito A, Brown DW, et al: Birth before 39 weeks' gestation is associated with worse outcomes in neonates with heart disease, Pediatrics 126(2):277-284, 2010. De Luca R, Boulvain M, Irion O, et al: Incidence of early neonatal mortality and morbid¬ity after late-preterm and term cesarean delivery, Pediatrics 123(6):e1064-e1071, 2009. Ecker JL, Kaimal A, Mercer BM, et al: Periviable birth, Am J Obstet Gynecol 213(5):604-614, 2015.
Engle WA, Tomashek KM, Wallman C: Late-preterm infants: a population at risk, Pediatrics 120(6):1390-1401, 2007.
Gyamfi-Bannerman C, Fuchs KM, Young OM, Hoffman MK: Nonspontaneous late preterm birth: etiology and outcomes, Am J Obstet Gynecol 205(5):e451-e456, 2011.
Harrison MS, Goldenberg RL: Global burden of prematurity, Semin Fetal Neonatal Med 21(2):74-79, 2016.
Helenius K, Sjors G, Shah PS, et al: Survival in very preterm infants: an international comparison of 10 national neonatal networks, Pediatrics 140(6):2017.
Hirai AH, Sappenfield WM, Kogan MD, et al: Contributors to excess infant mortality in the U.S. South, Am J Prev Med 46(3):219-227, 2014.
Holzman C, Eyster J, Kleyn M, et al: Maternal weathering and risk of preterm delivery, Am J Public Health 99(10):1864-1871, 2009.
Joseph KS, Liu S, Rouleau J, et al: Influence of definition based versus pragmatic birth registration on international comparisons of perinatal and infant mortality: population-based retrospective study, BMJ 344:e746, 2012.
Kramer MS, Platt RW, Yang H, et al: Registration artifacts in international comparisons of infant mortality, Paediatr Perinat Epidemiol 16(1):16-22, 2002.
The Lancet: Prevention of neural tube defects: results of the medical research council vitamin study, Lancet 338(8760):131-137, 1991.
Lawn JE, Blencowe H, Oza S, et al: Every newborn: progress, priorities, and potential beyond survival, Lancet 384:189-202, 2014.
Lu MC, Halfon N: Racial and ethnic disparities in birth outcomes: a life-course perspective, Matern Child Health J 7(1):13-30, 2003.
MacDorman MF, Hoyert DL, Mathews TJ: Recent declines in infant mortality in the United States, 2005-2011, NCHS Data Brief 120:1-8, 2013.
MacDorman MF, Matthews TJ, Mohangoo AD, Zeitlin J: International comparisons of infant mortality and related factors: United States and Europe, 2010, Natl Vital Stat Rep 63(5):1-6, 2014.
Macintosh MC, Fleming KM, Bailey JA, et al: Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and northern Ireland: population-based study, BMJ 333(7560):177, 2006.
Malloy MHL: Prematurity and sudden infant death syndrome: United States, 2005-2007, J Perinatol 33(6):470-475, 2013.
Martin JA, Hamilton BE, Osterman MJK, et al: Births: final data for 2015, Natl Vital Stat Rep 66(1):1-70, 2017.
Martin JA, Osterman MJ, Kirmeyer SE, Gregory EC: Measuring gestational age in vital statistics data: transitioning to the obstetric estimate, Natl Vital Stat Rep 64(5):1-20, 2015.
Newnham JP, Dickinson JE, Hart RJ, et al: Strategies to prevent preterm birth, Front Immunol 5:584, 2014.
Ngo TTM, Moufarrej MN, Rasmussen MLH, et al: Noninvasive blood tests for fetal development predict gestational age and preterm delivery, Science 360:1133-1136, 2018.
Norman JE, Marlow N, Messow CM, et al: Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicenter, randomized, double-blind trial, Lancet 387:2106-2116, 2016.
Oza S, Cousens SN, Lawn JE: Estimation of daily risk of neonatal death, including the day of birth, in 186 countries in 2013: a vital-registration and modelling-based study, Lancet Glob Health 2(11):e635-e644, 2014.
Patrick SW, Warner KE, Pordes E, Davis MM: Cigarette tax increase and infant mortality, Pediatrics 137(1):2016.
Platt MJ: Outcomes in preterm infants, Public Health 128(5):399-403, 2014.
Pulver LS, Guest-Warnick G, Stoddard GJ, et al: Weight for gestational age affects the mortality of late preterm infants, Pediatrics 123(6):e1072-e1077, 2009.
Rolnik DL, Wright D, Poon LC, et al: Aspirin versus placebo in pregnancies at high risk for preterm eclampsia, N Engl J Med 377(7):613-622, 2017.
Rubens CE, Sadovsky Y, Muglia L, et al: Prevention of preterm birth: harnessing science to address the global epidemic, Sci Transl Med 6(262):262-265, 2014.
Rysavy MA, Li L, Bell EF, et al: Between-hospital variation in treatment and outcomes in extremely preterm infants, N Engl J Med 372(19):1801-1811, 2015.
Saccone G, Maruotti GM, Giudicepietro A, et al: Effect of cervical pessary on spontaneous preterm birth in women with singleton pregnancies and short cervical length, JAMA 318(23):2317-2324, 2017.
Shapiro-Mendoza CK, Barfield WD, Henderson Z, et al: CDC grand rounds: public health strategies to prevent preterm birth, MMWR Morb Mortal Wkly Rep 65(32): 826-830, 2016.
Shapiro-Mendoza CK, Tomashek KM, Kotelchuck M, et al: Risk factors for neonatal morbidity and mortality among “healthy,” late preterm newborns, Semin Perinatol 30(2):54-60, 2006.
Task Force on Sudden Infant Death: SIDS and other sleep-related infant deaths: updated 2016 recommendations for a safe infant sleeping environment, Pediatrics 138(5):2016.
Walker KF, Thornton JG: Tocolysis and preterm labor, Lancet 387:2068-2070, 2016. Webb DA, Mathew L, Culhane JF: Lessons learned from the philadelphia collaborative preterm prevention project: the prevalence of risk factors and program participation rates among women in the intervention group, BMC Pregnancy Childbirth 14:368, 2014.
Wise PH: Confronting racial disparities in infant mortality: reconciling science and politics, Am J Prev Med 9(6 Suppl):7-16, 1993.
Wise PHL: The anatomy of a disparity in infant mortality, Annu Rev Public Health 24:341-362, 2003.
Zhang G, Feenstra B, Bacelis J, et al: Genetic associations with gestational duration and spontaneous preterm birth, N Engl J Med 377(12):1156-1167, 2017.
Buryk M, Bloom D, Shope T: Efficacy of neonatal release of ankyloglossia: a randomized trial, Pediatrics 128:280-288, 2011.
Deshpande SA, Jog S, Watson H, et al: Do babies with isolated single umbilical artery need routine postnatal renal ultrasonography?, Arch Dis Child Fetal Neonatal Ed F265-F267, 2009.
De-Wahl Granelli A, Wennergren M, Sandberg K, et al: Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39821 newborns, BMJ 338:a3037, 2009.
Dubnov-Raz G, Merlob P, Geva-Dayan K, et al: Increased rate of major birth malformations in infants with neonatal “asymmetric crying face”: a hospital-based cohort study, Am J Med Genet A 143A:305-310, 2007.
Ewer AK, Martin GR: Newborn pulse oximetry screening: which algorithm is best?, Pediatrics 138(5):e20161206, 2016.
Heyman SRG, Vervloessem D: Bryant's and Stabler's signs after a difficult delivery, N Engl J Med 365:1824-1825, 2011.
Mahle WT, Martin GR, Beekman RH III, et al: Endorsement of health and human services recommendation for pulse oximetry screening for critical congenital heart disease, Pediatrics 129:190-192, 2012.
Manzoni P, Martin GR, Luna MS, et al: Pulse oximetry screening for critical congenital heart defects: a European consensus statement, Lancet 1:88-90, 2017.
Mullany LC, Katz J, Khatry SK, et al: Incidence and seasonality of hypothermia among newborns in southern Nepal, Arch Pediatr Adolesc Med 164:71-77, 2010.
Plana M, Zamora J, Suresh G, et al: Pulse oximetry screening for critical congenital heart defects, Cochrane Database Syst Rev (3):CD011912, 2018.
Shaked O, Tepper R, Klein Z, et al: Hydrometrocolpos—diagnostic and therapeutic dilemmas, J Pediatr Adolesc Gynecol 21:317-321, 2008.
Tzvi-Behr S, Megged O, Schlesinger Y, et al: Subcutaneous fat necrosis, J Pediatr 163:300, 2013.
Walsh J, Tunkel D: Diagnosis and treatment of ankyloglossia in newborns and infants: a review, JAMA Otolaryngol Head Neck Surg 143(1):1032-1039, 2017.
Watts P, Maguire S, Kwok T, et al: Newborn retinal hemorrhages: a systematic review, J AAPOS 17:70-78, 2013.
American Academy of Pediatrics and The American College of Obstetricians and Gynecologists: Care of the newborn. In Guidelines for perinatal care, ed 7, Elk Grove Village, IL, 2012, American Academy of Pediatrics.
American Academy of Pediatrics, American College of Obstetricians and Gynecologists: Delayed umbilical cord clamping after birth, committee opinion 684, Obstet Gynecol 129(1):e5-e10, 2017.
American Academy of Pediatrics Committee on Fetus and Newborn: Hospital stay for healthy term newborn infants, Pediatrics 135:948-953, 2015.
American Academy of Pediatrics Committee on Fetus and Newborn: The apgar score, Pediatrics 136(4):2015.
American Academy of Pediatrics Committee on Fetus and Newborn: Umbilical cord care in the newborn infant, Pediatrics 138(3):2016.
Ashish KC, Rana N, Malqvist M, et al: Effects of delayed umbilical cord clamping vs early clamping on anemia in infants at 8 and 12 months, JAMA Pediatr 171(3):265-270, 2017.
Baley JL: Skin-to-skin care for term and preterm infants in the neonatal ICU, Pediatrics 136(3):596-599, 2015.
Centers for Disease Control and Prevention: Impact of expanded newborn screening—United States, 2006, MMWR Morb Mortal Wkly Rep 57:1012-1015, 2008.
Gras-Le-Guen C, Caille A, Launay E, et al: Dry care versus antiseptics for umbilical cord care: a cluster randomized trial, Pediatrics 139(1):2016.
Kelleher J, Bhat R, Salas AA: Oronasopharyngeal suction versus wiping of the mouth and nose at birth: a randomized equivalency trial, Lancet 382:326-330, 2013.
Lie KK, Gr0holt EK, Eskild A: Association of cerebral palsy with apgar score in low and normal birthweight infants: population based cohort study, BMJ 341:817, 2010. Malloy M: Chorioamnionitis: epidemiology of newborn management and outcome United States 2008, J Perinatol 34(8):611-615, 2014.
Morton C, Nance W: Newborn hearing screening—a silent revolution, N Engl J Med 354(20):2151-2164, 2006.
Ottolini M, Lundgren K, Mirkinson L, et al: Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn, Pediatr Infect Dis J 22(5):430-434, 2003.
Paneth N: Apgar score and risk of cerebral palsy, BMJ 341:788-789, 2010.
Puckett RM, Offringa M: Prophylactic vitamin K for vitamin K deficiency bleeding in neonates, Cochrane Database Syst Rev (4):CD002776, 2000.
Stewart D, Benitz W, et al: Umbilical cord care in the newborn infant, Pediatrics 138(3):2016.
Velaphi S, Perlman J: Wiping versus suction to clear neonatal airways at birth, Lancet 382:290-291, 2013.
Wilcken B, Haas M, Joy P, et al: Expanded newborn screening: outcome in screened and unscreened patients at age 6 years, Pediatrics 124:e241-e248, 2009.
World Health Organization: Recommendations on postnatal care of the mother and newborn, Geneva, 2013, WHO.
American Academy of Pediatrics Task Force on Circumcision: Circumcision policy statement, Pediatrics 130:585-586, 2012.
American Academy of Pediatrics Task Force on Circumcision: Technical report, male circumcision, Pediatrics 130:e756-e785, 2012.
Lander J, Brady-Fryer B, Metcalfe JB, et al: Comparison of ring block, dorsal penile nerve block, and topical anesthesia for neonatal circumcision: a randomized controlled trial, JAMA 278:2157-2162, 1997.
Sansom SL, Prabhu VS, Hutchinson AB, et al: Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males, PLoS ONE 5:e8723, 2010.
Sharara-Chami R, Lakissian Z, Charafeddine L, et al: Combination analgesia for neonatal circumcision: a randomized controlled trial, Pediatrics 140(6):e20171935, 2017.
Singh-Grewal D, Macdessi J, Craig J: Circumcision for the prevention of urinary tract infection in boys: a systematic review of randomised trials and observational studies, Arch Dis Child 90:853-858, 2005.
Stevens B, Yamada J, Ohlsson A, et al: Sucrose for analgesia in newborn infants undergoing painful procedures, Cochrane Database Syst Rev (7):CD001069, 2016.
American Academy of Pediatrics, Committee on Pediatric AIDS: Infant feeding and transmission of human immunodeficiency virus in the United States, Pediatrics 131:391-396, 2013.
American Academy of Pediatrics, Section on Breastfeeding: Breastfeeding and the use of human milk, Pediatrics 129:e827-e841, 2012.
Becker GE, Remmington S, Remmington T: Early additional food and fluids for healthy breastfed full-term infants, Cochrane Database Syst Rev (12):CD006462, 2011.
Keim SA, Hogan JS, McNamara KA, et al: Microbial contamination of human milk purchased via the internet, Pediatrics 132:e1227-e1235, 2013.
Kennell JH, Klaus MH: Bonding: recent observations that alter perinatal care, Pediatr Rev 19:4-12, 1998.
Neu J, Sullivan S: Baby and breast: a dynamic interaction, Pediatr Res 71:135, 2012.
Perrine CG, Galuska DA, Dohack JL, et al: Vital signs: improvements in maternity care policies and practices that support breastfeeding—United States, 2007-2013, MMWR Morb Mortal Wkly Rep 64:1112-1117, 2015.
Reece-Stremtan S, Marinelli K: ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015, Breastfeed Med 10(3):135-141, 2015.
Sachs HC, American Academy of Pediatrics Committee on Drugs: The transfer of drugs and therapeutics into human breast milk: an update on selected topics, Pediatrics 132:e796-e809, 2013.
World Health Organization, United Nations Children's Fund: Updates on HIV and infant feeding: the duration of breastfeeding, and support from health services to improve feeding practices among mothers living with HIV, Geneva, 2016, WHO.
Abele H, Starz S, Hoopmann M, et al: Idiopathic polyhydramnios and postnatal abnormalities, Fetal Diagn Ther 32:251, 2012.
American College of Obstetricians and Gynecologists: Obstetric analgesia and anesthesia, ACOG Practice Bulletin No 36, Obstet Gynecol 100:177-191, 2002.
American College of Obstetricians and Gynecologists: Operative vaginal delivery, ACOG Practice Bulletin No 154, Obstet Gynecol 126:e56-e65, 2015.
American College of Obstetricians and Gynecologists: Management of preterm labor, ACOG Practice Bulletin No 171, Obstet Gynecol 128:e155-e164, 2016.
American College of Obstetricians and Gynecologists: Premature rupture of membranes, ACOG Practice Bulletin No 172, Obstet Gynecol 128:e165-e177, 2016.
Charlier C, Beaudoin MC, Couderc T, et al: Arbovirused and pregnancy: maternal, fetal, and neonatal effects, Lancet 1:134-146, 2017.
Davies MJ, Moore VM, Willson KJ, et al: Reproductive technologies and the risk of birth defects, N Engl J Med 366(19):1803-1812, 2012.
De Fatima Vasco Aragao M, et al: Clinical features and neuroimaging (CT and MRI) findings in presumed Zika virus related congenital infection and microcephaly: retrospective case series study, BMJ 353:i1901, 2016.
De Luca R, et al: Incidence of early neonatal mortality and morbidity after late-preterm and term cesarean delivery, Pediatrics 123(6):e1064-e1071, 2009.
Delaney C, Cornfield DN: Risk factors for persistent pulmonary hypertension of the newborn, Pulm Circ 2(1):15-20, 2012.
Dorleijn DM, Cohen-Overbeek TE, Groenendaal F, et al: Idiopathic polyhydramnios and postnatal findings, J Matern Fetal Neonatal Med 22:315, 2009.
Ecker JL, Frigoletto FD Jr: Cesarean delivery and the risk-benefit calculus, N Engl J Med 356:885-888, 2007.
Glavind J, et al: Neonatal morbidity after spontaneous labor onset prior to intended cesarean delivery at term: a cohort study, Acta Obstet Gynecol Scand 96(4):479-486, 2017.
Jagota P, Vincent A, Bhidayasiri R: Transplacental transfer of NMDA receptor antibodies in an infant with cortical dysplasia, Neurology 82:1662-1663, 2014.
Laghmani K, Beck BB, Yang SS, et al: Polyhydramnios, transient antenatal Bartter's syndrome, and MAGED 2 mutations, N Engl J Med 374(19):1853-1862, 2016.
Mussa A, Molinatto C, Cerrato F, et al: Assisted reproductive techniques and risk of Beckwith-Wiedemann syndrome, Pediatrics 140(1):2016.
Sousa AQ, et al: Postmortem findings for 7 neonates with congenital Zika virus infection, Emerg Infect Dis 23(7):2017.
Steer PJ, Modi N: Elective caesarean sections—risks to the infant, Lancet 374:675-676, 2009.
Touboul C, Boileau P, Picone O, et al: Outcome of children born out of pregnancies complicated by unexplained polyhydramnios, BJOG 114:489, 2007.
Touboul C, Picone O, Levaillant JM, et al: Clinical application of fetal urine production rate in unexplained polyhydramnios, Ultrasound Obstet Gynecol 34:521, 2009.
American College of Obstetricians and Gynecologists: Fetal growth restriction, ACOG practice bulletin no 134, Obstet Gynecol 121:1122-1133, 2013.
American College of Obstetricians and Gynecologists: Method for estimating due date, ACOG committee opinion no 611, Obstet Gynecol 124:863-866, 2014.
American College of Obstetricians and Gynecologists: Ultrasound in pregnancy, ACOG practice bulletin no 175, Obstet Gynecol 128:e241-e256, 2016.
Griffiths PD, Bradburn M, Campbell MJ, et al: Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multi-centre, prospective cohort study, Lancet 389:538-546, 2017.
Grimes DA: When to deliver a stunted fetus, Lancet 364:483-484, 2004.
Lee ACC, Katz J, Blencowe H, et al: National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010, Lancet 1:e26-e36, 2013.
Nielsen BW, Scott RC: Brain abnormalities in fetuses: in-utero MRI versus ultrasound, Lancet 389:483-484, 2017.
Ott WJ: Intrauterine growth restriction and doppler ultrasonography, J Ultrasound Med 19:661-665, 2000.
Papageorghiou AT, Ohyma EO, Altman DG, et al: International standards for fetal growth based on serial ultrasound measurements: the fetal growth longitudinal study of the INTERGROWTH-21st project, Lancet 384:869-878, 2014.
Ray JG, Vermeulen MJ, Bharatha A, et al: Association between MRI exposure during pregnancy and fetal childhood outcomes, JAMA 316(9):952-961, 2016.
Romero R, Deter R: Should serial fetal biometry be used in all pregnancies?, Lancet 386:2038-2040, 2015.
Simchen MJ, Toi A, Bona M, et al: Fetal hepatic calcifications: prenatal diagnosis and outcome, Am J Obstet Gynecol 187(6):1617-1622, 2002.
Stock SJ, Bricker L, Norman JE: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes, Cochrane Database Syst Rev (7):CD008968, 2012.
American College of Obstetricians and Gynecologists: Fetal growth restriction, ACOG practice bulletin no 134, Obstet Gynecol 121:1122-1133, 2013.
American College of Obstetricians and Gynecologists: Method for estimating due date, ACOG committee opinion no 611, Obstet Gynecol 124:863-866, 2014.
American College of Obstetricians and Gynecologists: Ultrasound in pregnancy, ACOG practice bulletin no 175, Obstet Gynecol 128:e241-e256, 2016.
Griffiths PD, Bradburn M, Campbell MJ, et al: Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multi-centre, prospective cohort study, Lancet 389:538-546, 2017.
Grimes DA: When to deliver a stunted fetus, Lancet 364:483-484, 2004.
Lee ACC, Katz J, Blencowe H, et al: National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010, Lancet 1:e26-e36, 2013.
Nielsen BW, Scott RC: Brain abnormalities in fetuses: in-utero MRI versus ultrasound, Lancet 389:483-484, 2017.
Ott WJ: Intrauterine growth restriction and doppler ultrasonography, J Ultrasound Med 19:661-665, 2000.
Papageorghiou AT, Ohyma EO, Altman DG, et al: International standards for fetal growth based on serial ultrasound measurements: the fetal growth longitudinal study of the INTERGROWTH-21st project, Lancet 384:869-878, 2014.
Ray JG, Vermeulen MJ, Bharatha A, et al: Association between MRI exposure during pregnancy and fetal childhood outcomes, JAMA 316(9):952-961, 2016.
Romero R, Deter R: Should serial fetal biometry be used in all pregnancies?, Lancet 386:2038-2040, 2015.
Simchen MJ, Toi A, Bona M, et al: Fetal hepatic calcifications: prenatal diagnosis and outcome, Am J Obstet Gynecol 187(6):1617-1622, 2002.
Stock SJ, Bricker L, Norman JE: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes, Cochrane Database Syst Rev (7):CD008968, 2012.
American College of Obstetricians and Gynecologists: Pregestational diabetes mellitus, ACOG practice bulletin no 60, Obstet Gynecol 105:675-685, 2005.
American College of Obstetricians and Gynecologists: Gestational diabetes mellitus, ACOG ACOG practice bulletin no 137, Obstet Gynecol 122:406-416, 2013.
American College of Obstetricians and Gynecologists: Thyroid disease in pregnancy, ACOG practice bulletin no 148, Obstet Gynecol 125:996-1005, 2015.
American College of Obstetricians and Gynecologists: Cytomegalovirus, parvovirus b19, varicella-zoster, and toxoplasmosis in pregnancy, ACOG practice bulletin no 151, Obstet Gynecol 125:1510-1525, 2015.
American College of Obstetricians and Gynecologists: Management of women with phenylketonuria, ACOG committee opinion no 636, Obstet Gynecol 125:1548-1550, 2015.
Lockshin M, Salmon J, Erkan D: Pregnancy and rheumatic diseases. In Creasy RK, Resnik R, editors: Maternal-fetal medicine: principles and practice, ed 7, Philadelphia, 2014, Saunders.
Louik C, Lin A, Weler MM, et al: First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects, N Engl J Med 356:2675-2682, 2007.
Mol BWJ, Roberts CT, Thangaratinam S, et al: Pre-eclampsia, Lancet 387:999-1010, 2016. Waller DR, Shaw GM, Rasmussen SA, et al: Prepregnancy obesity as a risk factor for structural birth defects, Arch PediatrAdolesc Med 161:745-750, 2007.
Ackerman JP, Riggins T, Black MM: A review of the effects of prenatal cocaine exposure among school-aged children, Pediatrics 125:554-565, 2010.
Alwan S, Reefhuis J, Rasmussen SA, et al: Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects, N Engl J Med 356:2684-2692, 2007.
American College of Obstetricians and Gynecologists: Opioid abuse, dependence, and addiction in pregnancy. Committee opinion no 524, Obstet Gynecol 119:1070, 2012.
Andrade SE, Gurwitz JH, Davis RL, et al: Prescription drug use in pregnancy, Am J Obstet Gynecol 191:398-407, 2004.
Bromley RL, Weston J, Marson AG: Maternal use of antiepileptic agents during pregnancy and major congenital malformations in children, JAMA 318(17):1700-1701, 2017.
Broussard CS, Rasmussen SA, Reefhuis J, et al: Maternal treatment with opioid analgesics and risk for birth defects, Am J Obstet Gynecol 204:314.e1-314.e11, 2011.
Bullo M, Tschumi S, Bucher BS, et al: Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists, Hypertension 60:444-450, 2012.
Christensen J, Gronb0rg TK, S0rensen MJ, et al: Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism, JAMA 309:1696-1702, 2013.
Cummings C, Stewart M, Stevenson M, et al: Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine, Arch Dis Child 96:643-647, 2011.
DeMarini DM, Preston RJ: Smoking while pregnant: transplacental mutagenesis of the fetus by tobacco smoke, JAMA 293:1264-1265, 2005.
De-Regil LM, Fernandez-Gaxiola AC, Dowswell T, et al: Effects of safety and pericon- ceptional folate supplementation for preventing birth defects, Cochrane Database Syst Rev (10):CD007950, 2010.
De-Regil LM, Fernandez-Gaxiola AC, Dowswell T, et al: Effects of safety and pericon- ceptional folate supplementation for preventing birth defects, Cochrane Database Syst Rev (10):CD007950, 2010.
Djokanovic N, Klieger-Grossman C, Pupco A, et al: Safety of infliximab use during pregnancy, Reprod Toxicol 32:93-97, 2011.
Dubnov-Raz G, Juurlink DN, Fogelman R, et al: Antenatal use of selective serotonin- reuptake inhibitors and QT interval prolongation in newborns, Pediatrics 122: e710-e715, 2008.
Edison RJ, Muenke M: Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins, Am J Med Genet A 131A:287-298, 2004.
El Marroun H, Jaddoe VWV, Hudziak JJ, et al: Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes, Arch Gen Psychiatry 69:706-714, 2012.
Foulds N, Walpole I, Elmslie F, et al: Carbimazole embryopathy: an emerging phenotype, Am J Med Genet A 132:130-135, 2005.
Gill SK, O'Brien L, Einarson TR, et al: The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis, Am J Gastroenterol 104:1541-1545, 2009.
Graham JM Jr, Edwards MJ, Edwards MJ: Teratogen update: gestational effects of maternal hyperthermia due to febrile illnesses and resultant patterns of defects in humans, Teratology 58:209-221, 1998.
Hernandez-Duaz S, Smith CR, Shen A, et al: Comparative safety of antiepileptic drugs during pregnancy, Neurology 78:1692-1699, 2012.
Honein MA, Paulozzi LJ, Mathews TJ, et al: Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects, JAMA 285:2981-2986, 2001.
Jones HE, Kaltenbach K, Heil SH, et al: Neonatal abstinence syndrome after methadone or buprenorphine exposure, N Engl J Med 363:2320-2331, 2010.
Jones KJ, Lacro RV, Johnson KA, et al: Pattern of malformations in the children of women treated with carbamazepine during pregnancy, N Engl J Med 320:1661-1666, 1989.
Julsgaard M, Christensen LA, Gibson PR, et al: Concentrations of adalimumab and infliximab in mothers and newborns and effects on infection, Gastroenterology 151(1):110-119, 2016.
Kaufman RH, Adam E, Hatch EE, et al: Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring, Obstet Gynecol 96:483-489, 2000.
Khattak S, K-Moghtader G, McMartin K, et al: Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study, JAMA 281:1106-1109, 1999.
Koren G, Nordeng H: SSRIs and persistent pulmonary hypertension of the newborn, BMJ 344:d7642, 2012.
Koren G, Pastuszak A, Ito S: Drugs in pregnancy, N Engl J Med 338:1128-1137, 1998. Lammer EJ, Chen CT, Hoar RM, et al: Retinoic acid embryopathy, N Engl J Med 313:837-841, 1985.
Lund N, Pedersen LH, Henriksen TB: Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes, Arch Pediatr Adolesc Med 163:949-954, 2009.
Matok I, Gorodischer R, Koren G, et al: The safety of metoclopramide use in the first trimester of pregnancy, N Engl J Med 360:2528-2534, 2009.
Meador KJ, Baker GA, Browning N, et al: Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs, N Engl J Med 360:1507-1605, 2009.
Molgaard-Nielsen D, Hviid A: Newer-generation antiepileptic drugs and the risk of major birth defects, JAMA 305:1996-2002, 2011.
Moran LR, Almeida PG, Worden S, et al: Intrauterine baclofen exposure: a multidisciplinary approach, Pediatrics 114:e267-e269, 2004.
Moretti ME, Bar-Oz B, Fried S, et al: Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis, Epidemiology 16: 216-219, 2005.
Nadebaum C, Anderson VA, Vajda F, et al: Language skills of school-aged children prenatally exposed to antiepileptic drugs, Neurology 76:719-726, 2011.
Oei J, Abdel-Latif ME, Clark R, et al: Short-term outcomes of mothers and infants exposed to antenatal amphetamines, Arch Dis Child Fetal Neonatal Ed 95:F36-F41, 2010.
Patorno E, Huybrechts KF, Bateman BT, et al: Lithium use in pregnancy and the risk of cardiac malformations, N Engl J Med 376(23):2245-2254, 2017.
Persson M, Cnattingius S, Villamor E, et al: Risk of major congenital malformations in relation to maternal overweight and obesity severity: cohort study 1.2 million singletons, BMJ 357:2563, 2017.
Ramos E, St-Andre M, Rey E, et al: Duration of antidepressant use during pregnancy and risk of major congenital malformations, Br J Psych 192:344-350, 2008.
Ross LE, Grigoriadis S, Mamisahvili L, et al: Selected pregnancy and delivery outcomes after exposure to antidepressant medication, JAMA Psychiatry 70:436-443, 2013.
Seligman NS, Almario CV, Hayes EJ, et al: Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome, J Pediatr 157:428-433, 2010.
Seo GH, Kim TH, Chung JH: Antithyroid drugs and congenital malformations: a nationwide Korean cohort study, Ann Intern Med 168(6):405-413, 2018.
Shaw GM, Carmichael SL, Vollset SE, et al: Mid-pregnancy cotinine and risks of orofacial clefts and neural tube defects, J Pediatr 154:17-19, 2009.
Simon A, Warszawski J, Kariyawasam D, et al: Association of prenatal and postnatal exposure to lopinavir-ritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothers, JAMA 306:70-78, 2011.
Stephansson O, Kieler H, Haglund B, et al: Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality, JAMA 309:48-54, 2013.
Sujan AC, Rickert ME, Oberg S, et al: Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring, JAMA 217(15):1553-1562, 2017.
Tomson T, Battino D: Teratogenicity of antiepileptic drugs: state of the art, Curr Opin Neurol 18:135-140, 2005.
Tomson T, Battino D, Bonizzoni E, et al: Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry, Lancet Neurol 17(6):530-538, 2018.
Vento M, Aytes AP, Ledo A, et al: Mycophenolate mofetil during pregnancy: some words of caution, Pediatrics 122:184-185, 2008.
American College of Obstetricians and Gynecologists: Guidelines for diagnostic imaging during pregnancy and lactation, ACOG committee opinion no 656, Obstet Gynecol 127:e75-e80, 2016.
Brent RL: Saving lives and changing family histories: appropriate counseling of pregnant women and men and women of reproductive age, concerning the risk of diagnostic radiation exposures during and before pregnancy, Am J Obstet Gynecol 200:4-24, 2009.
American College of Obstetricians and Gynecologists: Cell-free DNA screening for fetal aneuploidy, ACOG committee opinion no 640, Obstet Gynecol 126:e31-e37, 2015.
American College of Obstetricians and Gynecologists: Microarrays and next-generation sequencing technology: the use of advanced genetic diagnostic tools in obstetrics and gynecology, ACOG committee opinion no 682, Obstet Gynecol 128:e262-e268, 2016.
American College of Obstetricians and Gynecologists: Prenatal diagnostic testing for genetic disorders, ACOG practice bulletin no 162, Obstet Gynecol 127:e108-e122, 2016.
American College of Obstetricians and Gynecologists: Screening for fetal aneuploidy, Practice bulletin no 163, Obstet Gynecol 127:e123-e137, 2016.
Barnes BT, Jelin AC, Gaur L, et al: Maternal sirolimus therapy for fetal cardiac rhabdomyomas, N Engl J Med 378(19):1844-1846, 2018.
Bianchi DW: From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges, Nat Med 18:1041-1051, 2012.
Devaney SA, Palomaki GE, Scott JA, et al: Noninvasive fetal sex determination using cell-free fetal DNA, JAMA 306:627-636, 2011.
Fan HC, Gu W, Wanf J, et al: Non-invasive prenatal measurement of the fetal genome, Nature 489:326-332, 2012.
Ismaili K, Avni FE, Wissing KM, et al: Long-term clinical outcome of infants with mild and moderate fetal pyelectasis: validation of neonatal ultrasound as a screening tool to detect significant nephrouropathies, J Pediatr 144:759-765, 2004.
The Lancet: Genome editing: science, ethics, and public engagement, Lancet 390:625, 2017.
Morris RK, Malin GL, Quinlan-Jones E, et al: Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomized trial, Lancet 382:1496-1506, 2013.
Nicolaides KH, Wright D, Poon C, et al: First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing, Ultrasound Obstet Gynecol 42:41-50, 2013.
Norton ME, Jacobsson B, Swamy GK, et al: Cell-free DNA analysis for noninvasive examination of trisomy, N Engl J Med 372(17):1589-1597, 2015.
Reddy UM, Page GP, Saade GR, et al: Karyotype versus microarray testing for genetic abnormalities after stillbirth, N Engl J Med 367:2185-2193, 2012.
Rychik J, Khalek N, Gaynor JW, et al: Fetal intrapericardial teratoma: natural history and management including successful in utero surgery, Am J Obstet Gynecol 215(6):780e1-780e7, 2016.
Snyder MW, Simmons LE, Kitzman JO, et al: Copy number variation and false positive prenatal aneuploidy screening results, N Engl J Med 372(17):1639-1645, 2015.
Stenhouse EJ, Crossley JA, Aitken DA, et al: First trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice, Prenat Diagn 24:774-780, 2004.
Talkowski ME, Ordulu Z, Pillalamarri V, et al: Clinical diagnosis by whole-genome sequencing of a prenatal sample, N Engl J Med 376:2226-2232, 2012.
Wapner RJ, Martin CL, Levy B, et al: Chromosomal microarray versus karyotyping for prenatal diagnosis, N Engl J Med 367:2175-2184, 2012.
American College of Obstetricians and Gynecologists: Neural tube defects, ACOG practice bulletin no 44, Obstet Gynecol 102:203-213, 2003.
American College of Obstetricians and Gynecologists: Magnesium sulfate before anticipated preterm birth for neuroprotection, ACOG committee opinion no 455, Obstet Gynecol 115:669-671, 2010.
American College of Obstetricians and Gynecologists: Maternal-fetal intervention and fetal care centers, ACOG committee opinion no 501, Obstet Gynecol 118:405-410, 2011.
American College of Obstetricians and Gynecologists: Antenatal corticosteroid therapy for fetal maturation, ACOG committee opinion no 677, Obstet Gynecol 128:e187-e194, 2016.
American College of Obstetricians and Gynecologists: Management of preterm labor, ACOG practice bulletin no 171, Obstet Gynecol 128:e155-e164, 2016.
Adzick NS, Thom EA, Spong CY, et al: A randomized trial of prenatal versus postnatal repair of myelomeningocele, N Engl J Med 364(11):993-1004, 2011.
Al-Maary J, Eastwood MP, Russo FM, et al: Fetal tracheal occlusion for severe pulmonary hypoplasia in isolated congenital diaphragmatic hernia: a systematic review and meta-analysis of survival, Ann Surg264(6):929-933, 2016.
Antiel RM, Flake AW: Responsible surgical innovation and research in maternal-fetal surgery, Semin Fetal Neonatal Med 22(6):423-427, 2017.
Belfort MA, Whitehead WE, Shamshirasz AA, et al: Fetoscopic open neural tube defect repair, Obstet Gynecol 129(4):734-743, 2017.
Bruner JP, Tulipan N, Paschall RL, et al: Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus, JAMA 282(19):1819-1825, 1999.
Derderian SC, Coleman AM, Jeanty C, et al: Favorable outcomes in high-risk congenital pulmonary airway malformations treated with multiple courses of maternal betamethasone, J Pediatr Surg 50(4):515-518, 2015.
Gebb J, Dar P, Rosner M, Evans MI: Long-term neurologic outcomes after common fetal interventions, Am J Obstet Gynecol 212:527.e1-527.e9, 2015.
Graf K, Kohl T, Neubauer BA, et al: Percutaneous minimally invasive fetoscopic surgery for spina bifida aperta. Part III. Neurosurgical intervention in the first postnatal year, Ultrasound Obstet Gynecol 47:158-161, 2016.
Harrison MR, Adzick NS, Bullard KM, et al: Correction of congenital diaphragmatic hernia in utero VII: a prospective trial, J Pediatr Surg 32(11):1637-1642, 1997.
Harrison MR, Adzick NS, Flake AW, et al: Correction of congenital diaphragmatic hernia in utero. VIII. Response of the hypoplastic lung to tracheal occlusion, J Pediatr Surg 31(10):1339-1348, 1996.
Harrison MR, Filly RA, Golbus MS, et al: Fetal treatment 1982, N Engl J Med 307(26):1651-1652, 1982.
Harrison MR, Keller RL, Hawgood SB, et al: A randomized trial of fetal endoscopic tracheal occlusion for severe fetal congenital diaphragmatic hernia, N Engl J Med 349(20):1916-1924, 2003.
Hedrick HL, Flake AW, Crombleholme TM, et al: The ex utero intrapartum therapy procedure for high-risk fetal lung lesions, J Pediatr Surg 40(6):1038-1043, discussion 44, 2005.
Kilby MD, Morris RK: Fetal therapy for the treatment of congenital bladder neck obstruction, Nat Rev Urol 11(7):412-419, 2014.
Kitagawa H, Pringle KC: Fetal surgery: a critical review, Pediatr Surg Int 33(4):421-433, 2017.
Leuthner SR: Fetal palliative care, Clin Perinatol 31:649-665, 2004.
Loh KC, Jelin E, Hirose S, et al: Microcystic congenital pulmonary airway malformation with hydrops fetalis: steroids vs open fetal resection, J Pediatr Surg 47(1):36-39, 2012.
Van Mieghem T, Ryan G: The PLUTO trial: a missed opportunity, Lancet 382:1471-1472, 2013.
Vrecenak JD, Flake AW: Fetal surgical intervention: progress and perspectives, Pediatr Surg Int 29(5):407-417, 2013.
Asztalos EV, Hannah ME, Hutton EK, et al: Twin birth study: 2-year neurodevelopmental follow-up of the randomized trial of planned cesarean or planned vaginal delivery for twin pregnancy, Am J Obstet Gynecol 214:371.e1-371.e19, 2016.
Barrett JFR, Hannah ME, Hutton EK, et al: A randomized trial of planned cesarean or vaginal delivery for twin pregnancy, N Engl J Med 369:1295-1304, 2013.
Castillo-Fernandez JE, Spector TD, Bell JT: Epigenetics of discordant monozygotic twins: implications for disease, Genome Med 6(7):60, 2014.
Cheong-See F, Schuit E, Arroyo-Manzano D, et al: Prospective risk of stillbirth and neonatal complications in twin pregnancies: systematic review and meta-analysis, BMJ 354:i4353, 2016.
Dodd JM, Crowther CA, Haslam RR, et al: Elective birth at 37 weeks of gestation versus standard care for women with uncomplicated twin pregnancy at term: the twins timing of birth randomized trial, BJOG 119:964-974, 2012.
Fraga MF, Ballestar E, Paz MF, et al: Epigenetic differences arise during the lifetime of monozygotic twins, Proc Natl Acad Sci USA 102:10606-10609, 2005.
Hamilton B, Martin J, Osterman M, et al: Births: final data for 2014, Natl Vital Stat Rep 64(12):2015.
Hecher K, Gardiner HM, Diemert A, Bartmann P: Long-term outcomes for mono- chorionic twins after laser therapy in town-to-twin transfusion syndrome, Lancet 2:525-534, 2018.
Herranz G: The timing of monozygotic twinning: a criticism of the common model, Zygote 23(1):27-40, 2015.
Kulkarni AD, Jamieson DJ, Jones HW Jr, et al: Fertility treatments and multiple births in the United States, N Engl J Med 369(23):2218-2225, 2013.
McNamara HC, Kane SC, Craig JM, et al: A review of the mechanisms and evidence for typical and atypical twinning, Am J Obstet Gynecol 214(2):172-191, 2016.
Slaghekke F, Lopriore E, Lewi L, et al: Fetoscopic laser coagulation of the vascular equator versus selective coagulation for twin-to-twin transfusion syndrome: an open-label randomized controlled trial, Lancet 383:2144-2150, 2014.
Vitthala S, Gelbaya TA, Brison DR, et al: The risk of monozygotic twins after assisted reproductive technology: a systematic review and meta-analysis, Hum Reprod Update 15(1):45-55, 2009.
Wadhawan R, Oh W, Vohr BR, et al: Neurodevelopmental outcomes of triplets or higher-order extremely low birth weight infants, Pediatrics 127:e654-e660, 2011.
Adams M, Bassler D, Bucher HU, et al: Variability of very low birth weight infant outcome and practice in Swiss and US neonatal units, Pediatrics 141(5):e20173436, 2018.
American Academy of Pediatrics, Committee on Nutrition: Section of breastfeeding, Committee on fetus and newborn: donor human milk for the high-risk infant: preparation, safety, and usage options in the United States, Pediatrics 139(1): e20163440, 2017.
Cheong JLY, Anderson PJ, Burnett AC, et al: Changing neurodevelopment at 8 years in children born extremely preterm since the, Pediatrics 139(6):e20164086-2017, 1990s.
Cummings JJ, Polin RA: Committee on fetus and newborn: oxygen targeting in extremely low birth weight infants, Pediatrics 138:e20161576, 2016.
Frey HA, Klebanoff MA: The epidemiology, etiology, and costs of preterm birth, Semin Fetal Neonatal Med 21:68-73, 2016.
Gephart SM, Hanson CK: Preventing necrotizing enterocolitis with standardized feeding protocols: not only possible, but imperative, Adv Neonatal Care 13:48-54, 2013.
Glass HC, Costarino AT, Stayer SA, et al: Outcomes for extremely premature infants, Anesth Analg 120(6):1337-1351, 2015.
Harding JE, Cormack BE, Alexander T, et al: Advances in nutrition of the newborn infant, Lancet 389:1660-1668, 2017.
Horbar JD, Carpenter JH, Badger GJ, et al: Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009, Pediatrics 129:1019-1026, 2012.
Inoue H, Ochiai M, Yasuoka K, et al: Early mortality and morbidity in infants with birth weight of 500 grams or less in Japan, J Pediatr 190:112-117, 2017.
Kilpatrick SJ, Papile L, editors: Guidelines for perinatal care, ed 8, American Academy of Pediatrics, 2017, American College of Obstetricians and Gynecologists.
Koletzko B, Poindexter B, Uauy R, editors: Nutritional care of preterm infants: scientific basis and practical guidelines, ed 3, Basel, 2014, Karger AG.
Maas C, Mathes M, Bleeker C, et al: Effect of increased enteral protein intake on growth in human milk-fed preterm infants: a randomized clinical trial, JAMA Pediatr 171(1):16-22, 2017.
McNelis K, Fu TT, Poindexter B: Nutrition for the extremely preterm infant, Clin Perinatol 44:395-406, 2017.
Meier P, Patel A, Esquerra-Zwiers A: Donor human milk update: evidence, mechanisms, and priorities for research and practice, J Pediatr 180:15-21, 2017.
Ngo TTM, Moufarrej MN, Rasmussen MLH, et al: Noninvasive blood rests for fetal development predict gestational age and preterm delivery, Science 360:1133-1136, 2018.
O'Connor DL, Gibbins S, Kiss A, et al: Effect of supplemental donor human milk compared with preterm formula on neurodevelopment of very low-birth-weight infants at 18 months: a randomized clinical trial, JAMA 316(18):1897-1905, 2016. Shapiro-Mendoza CK, Barfield WD, Henderson Z, et al: CDC grand rounds: public health strategies to prevent preterm birth, MMWR Morb Mortal Wkly Rep 65(32):826-830, 2016.
Stoll BJ, Hansen HI, Bell EF, et al: Neonatal outcomes of extremely preterm infants from the NICHD neonatal research network, Pediatrics 126:443-455, 2010.
Twilhaar ES, Wade RM, de Kleviet JF, et al: Cognitive outcomes of children born extremely or very preterm since the 1990s and associated risk factors: a meta-analysis and meta-regression, JAMA Pediatr 172(4):361-367, 2018.
Van Puffelen E, Vanhorebeck I, Joosten KFM, et al: Early versus late parenteral nutrition in critically ill, term neonates: a preplanned secondary subgroup analysis of the PEPaNIC multicenter, randomized controlled trial, Lancet Child Adolesc Health 2:505-515, 2018.
Younge N, Goldstein RF, Bann CM, et al: Survival and neurodevelopmental outcomes among periviable infants, N Engl J Med 376:617-628, 2017.
Zhang G, Feenstra B, Bacelis J, et al: Genetic associations with gestational duration and spontaneous preterm birth, N Engl J Med 337:1156-1167, 2017.
American College of Obstetricians and Gynecologists: Antenatal corticosteroid therapy for fetal maturation, ACOG committee opinion no 713, Obstet Gynecol 130:e102-e109, 2017.
Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al: Antenatal betamethasone for women at risk for late preterm delivery, N Engl J Med 374:1311-1320, 2016.
Kugelman A, Colin AA: Late preterm infants: near term but still in a critical developmental time period, Pediatrics 132:741-751, 2013.
Trembath AN, Payne AH, Colaizy TT, et al: The problems of moderate preterm infants, Semin Perinatol 40:370-373, 2016.
Woythaler M, McCormick MC, Mao WY, et al: Late preterm infants and neurodevel- opmental outcomes at kindergarten, Pediatrics 136:424-431, 2015.
Bailit JL, Grobman W, Zhao Y, et al: Non-medically indicated induction vs. expectant management in term nulliparas, Am J Obstet Gynecol 212:130.e1-103.e7, 2015.
Begemann M, Zirn B, Santen G, et al: Paternally inherited IGF2 mutation and growth restriction, N Engl J Med 373(4):349-356, 2015.
Beukers F, Aaronoudse-Moens CSH, van Weissenbruch MM, et al: Fetal growth restriction with brain sparing: neurocognitive and behavioral outcomes at 12 years of age, J Pediatr 188:103-109, 2017.
Chiossi G, Lai Y, Landon MB, et al: Timing of delivery and adverse outcomes in term singleton repeat cesarean deliveries, Obstet Gynecol 121:561-569, 2014.
De Jesus LC, Pappas A, Shankaran S, et al: Outcomes of small for gestational age infants born <27 weeks gestation, J Pediatr 163:55-60, 2013.
Korzeniewski SJ, Allred EN, Joseph RM, et al: Neurodevelopment at age 10 years of children born <28 weeks with fetal growth restriction, Pediatrics 140(5):e20170697, 2017.
Li N, Li Z, Ye R, et al: Impact of periconceptional folic acid supplementation on low birth weight and small-for-gestational-age infants in China: a large prospective cohort study, J Pediatr 187:105-110, 2017.
Linder N, Hiersch L, Friedman E, et al: Post-term pregnancy is an independent risk factor for neonatal morbidity even in low-risk singleton pregnancies, Arch Dis Child Fetal Neonatal Ed 102:F286-F290, 2017.
Lhaugen GCC, 0stgard HF, Andreassen S, et al: Small for gestational age and intrauterine growth restriction decreases cognitive function in young adults, J Pediatr 163:447-453, 2013.
Morken NH, Klungs0yr K: Skjaeven r: perinatal mortality by gestational week and size at birth in singleton pregnancies at and beyond term: a nationwide population-based cohort study, BMC Pregnancy Childbirth 14:172, 2014.
Takeuchi A, Yorifuji T, Nakamura K, et al: Catch-up growth and neurobehavioral development among full-term, small-for-gestational-age children: a nationwide Japanese population-based study, J Pediatr 192:41-46, 2018.
American Academy of Pediatrics: Follow-up care of high-risk infants, Pediatrics 114:1377-1397, 2004.
American Academy of Pediatrics Committee on Fetus and Newborn: Hospital discharge of the high-risk neonate, Pediatrics 122:1119-1126, 2008.
Morgan C, Crowle C, Goyen T, et al: Sensitivity and specificity of general movements assessment for diagnostic accuracy of detecting cerebral palsy in an Australian context, J Paediatr Child Health 52:54-59, 2016.
Novak I, Morgan C, Adde L: Early, accurate diagnosis and early intervention in cerebral palsy advances in diagnosis and treatment, JAMA Pediatr 171:897-907, 2017.
Schmidt B, Asztalos EV, Roberts RS, et al: Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms, JAMA 289:1124-1129, 2003.
Spittle A, Orton J, Anderson PJ, et al: Early developmental intervention programmes provide post hospital discharge to prevent motor and cognitive impairment in preterm infants, Cochrane Database Syst Rev (11):CD005495, 1-107, 2015.
American Academy of Pediatrics Committee on Fetus and Newborn: Levels of neonatal care, Pediatrics 130:587-597, 2012.
Berns DS, editor: Toward improving the outcome of pregnancy. III. Enhancing perinatal health through quality, safety and performance initiatives, White Plains, NY, 2011, March of Dimes Foundation.
Campbell DM: Dadiz, R: simulation in neonatal transport medicine, SeminPerinatol 40:430-437, 2016.
Cheng ASM, Berry A, Jones LJ, Sivasangari S: Specialist teams for neonatal transport to neonatal intensive care units for prevention of morbidity and mortality, Cochrane Database Syst Rev (10):CD007485, 2015.
Lasswell SM, Barfield WD, Rochat RW, Blackmon L: Perinatal regionalization for very low-birth-weight and very preterm infants: a meta-analysis, JAMA 304:992-1000, 2010.
Lorch SA, Baiocchi M, Ahlberg CE, Small DS: The differential impact of delivery hospital on the outcomes of premature infants, Pediatrics 130:270-278, 2012.
Lorch SA, Myers S, Carr B: The regionalization of pediatric health care, Pediatrics 126:1182-1190, 2010.
American Academy of Pediatrics Committee on Fetus and Newborn: Section on anesthesiology and pain medicine: prevention and management of procedural pain in the neonate: an update, Pediatrics 137(2):e20154271, 2016.
Anand KJS: International Evidence-based group for neonatal pain: consensus statement for the prevention and management of pain in the newborn, Arch PediatrAdolesc Med 155:173-180, 2001.
Armentrout DC, Caple J: The jittery newborn, J Pediatr Health Care 15(3):147-149, 2001.
Brady-Fryer B, Wiebe N, Lander JA: Pain relief for neonatal circumcision, Cochrane Database Syst Rev (3):CD004217, 2005.
Brunquell PJ, Glennon CM, DiMario FJ, et al: Prediction of outcome based on clinical seizure type in newborn infants, J Pediatr 140:707-712, 2002.
Burge DM: The management of bilious vomiting in the neonate, Early Hum Dev 102:41-45, 2016.
Cortey A, Elzaabi M, Waegemans T, et al: Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis, Arch Pediatr 21(9):976-983, 2014.
Derbyshire SWG: Can fetuses feel pain?, BMJ 332:909-912, 2006.
Franck LS, Allen A, Cox S, et al: Parents' view about infant pain in neonatal intensive care, Clin J Pain 21:133-139, 2005.
Glass HC, Pham TN, Danielsen B, et al: Antenatal and intrapartum risk factors for seizures in term newborns: a population-based study, California 1998-2002, J Pediatr 154:24-28, 2009.
Izraelit A, Ten V, Krishnamurthy G, Ratner V: Neonatal cyanosis: diagnostic and management challenges, ISRN Pediatr 2011(3):175931-175934, 2011.
Levene M: The clinical conundrum of neonatal seizures, Arch Dis Child Fetal Neonatal Ed F75-F77, 2002.
Lloyd RO, O'Toole JM, Pavlidis E, et al: Electrographic seizures during the early postnatal period in preterm infants, J Pediatr 187:18-25, 2017.
Marokakis S, Kasparian NA, Kennedy SE: Prenatal counselling for congenital anomalies: a systematic review, PrenatDiagn 36:662-671, 2016.
Ng PC, Lee CH, Lam CWK, et al: Transient adrenocortical insufficiency of prematurity and systemic hypotension in very low birthweight infants, Arch Dis Child 89:F119-F126, 2004.
Rios DR, Kaiser JR: Vasopressin versus dopamine for treatment of hypotension in extremely low birth weight infants: a randomized, blinded pilot study, J Pediatr 166:850-855, 2015.
Taddio A, Lee C, Yip A, et al: Intravenous morphine and topical tetracaine for treatment of pain in preterm neonates undergoing central line placement, JAMA 295:793-800, 2006.
Watterberg KL: Hydrocortisone dosing for hypotension in newborn infants: less is more, J Pediatr 174:23-26, 2016.
Velasco R, Gomez B, Hernandez-Bou S, et al: Validation of a predictive model for identifying febrile young infants with altered urinalysis at low risk of invasive bacterial infection, Eur J ClinMicrobiol Infect Dis 36(2):281-284, 2017.
Pinheiro JM, Furdon SA, Boynton S, et al: Decreasing hypothermia during delivery room stabilization of preterm neonates, Pediatrics 133(1):e218-e226, 2014.
Abrams ME, Meredith KS, Kinnard P, Clark RH: Hydrops fetalis: a retrospective review of cases reported to a large national database and identification of risk factors associated with death, Pediatrics 120(1):84–89, 2007.
Desilets V, Audibert F: Investigation and management of non-immune fetal hydrops, J ObstetGynaecol Can 35(10):923–938, 2013.
Cho WI, Yu HW, Chung HR, et al: Clinical and laboratory characteristics of neonatal hypocalcemia, Ann PediatrEndocrinolMetab 20(2):86–91, 2015.
Thomas TC, Smith JM, White PC, Adhikari S: Transient neonatal hypocalcemia: presentation and outcomes, Pediatrics 129(6):e1461–e1467, 2012.
Alderliesten T, Lemmers PMA, Smarius JJM, et al: Cerebral oxygenation, extraction, and autoregulation in very preterm infants who develop peri-intraventricular hemorrhage, J Pediatr 162:698-704, 2013.
Armstrong-Wells J, Johnston SC, Wu YW, et al: Prevalence and predictors of perinatal hemorrhagic stroke: results from the kaiser pediatric stroke study, Pediatrics 123:823-828, 2009.
Back SA: Brain injury in the preterm infant: new horizons for pathogenesis and prevention, Pediat Neurol 53:185-192, 2015.
Ballabh P: Intraventricular hemorrhage in premature infants: mechanism of disease, Pediatr Res 67:1-8, 2010.
Bassan H, Limperopoulos C, Visconti K, et al: Neurodevelopmental outcome in survivors of periventricular hemorrhagic infarction, Pediatrics 120:785-792, 2007.
Bolisetty S, Dhawan A, Abdel-Latif M, et al: Intraventricular hemorrhage and neuro- developmental outcomes in extreme preterm infants, Pediatrics 133:55-62, 2014.
Broitman E, Ambalavanan N, Higgins RD, et al: Clinical data predict neurodevelop- mental outcome better than head ultrasound in extremely low birth weight infants, J Pediatr 151:500-505, 2007.
Brouwer A, Groenendaal F, Van Haastert IL, et al: Neurodevelopmental outcome of preterm infants with severe intraventricular hemorrhage and therapy for posthemorrhagic ventricular dilatation, J Pediatr 152:648-654, 2008.
Chau V, Brant R, Poskitt KJ, et al: Postnatal infection is associated with widespread abnormalities of brain development in premature newborns, Pediatr Res 71:274-279, 2012.
De Vries LS, Groenendaal F, Liem KD, et al: Treatment thresholds for intervention in posthaemorrhagic ventricular dilation: a randomized controlled trial, Arch Dis Child Fetal Neonatal Ed 2018. doi:10.1136/archdischild-2017-314206. [Epub ahead of print]. Fowlie PW, Davis PG, McGuire W: Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants, Cochrane Database Syst Rev (7):CD000174, 2010.
Gano D, Ho ML, Partridge JC, et al: Antenatal exposure to magnesium sulfate is associated with reduced cerebellar hemorrhage in preterm newborns, J Pediatr 178:68-74, 2016.
Hintz SR, Barnes PD, Bulas D, et al: Neuroimaging and neurodevelopmental outcome in extremely preterm infants, Pediatrics 135:e32-e42, 2015.
Rooks VJ, Eaton JP, Ruess L, et al: Prevalence and evolution of intracranial hemorrhage in asymptomatic term infants, AJNR Am J Neuroradiol 29:1082-1089, 2008.
Roze E, Van Braeckel KNJA, van der Veere CH, et al: Functional outcome at school age of preterm infants with periventricular hemorrhagic infarction, Pediatrics 123:1493-1500, 2009.
Sarkar S, Shankaran S, Barks J, et al: Outcome of preterm infants with transient cystic perventricular leukomalacia on serial cranial imaging up to term equivalent age, J Pediatr 195:59-65, 2018.
Sirgiovanni I, Avignone S, Groppo M, et al: Intracranial haemorrhage: an incidental finding at magnetic resonance imaging in a cohort of late preterm and term infants, Pediatr Radiol 44(3):289-296, 2014.
Vincer MJ, Allen AC, Joseph KS, et al: Increasing prevalence of cerebral palsy among very preterm infants: a population-based study, Pediatrics 118:e1621-e1626, 2006.
Whitby EH, Griffiths PD, Rutter S, et al: Frequency and natural history of subdural haemorrhages in babies and relation to obstetric factors, Lancet 362:846-851, 2003.
Whitelaw A, Lee-Kelland R: Repeated lumbar or ventricular punctures in newborns with intraventricular hemorrhage, Cochrane Database Syst Rev (1):CD000216, 2017.
Ahmad KA, Desai SJ, Bennett MM, et al: Changing antiepileptic drug use for seizures in US neonatal intensive care units from 2005 to 2014, JPerinatol 37:296-300, 2017.
Ambalavanan N, Carlo WA, Shankaran S, et al: Predicting outcomes of neonates diagnosed with hypoxic-ischemic encephalopathy, Pediatrics 118:2084-2093, 2006.
Avasiloaiei A, Dimitriu C, Moscalu M, et al: High-dose phenobarbital or erythropoietin for the treatment of perinatal asphyxia in term newborns, Pediatr Int 55:589-593, 2013.
Azzopardi DV, Strohm B, Edward AD, et al: Moderate hypothermia to treat perinatal asphyxial encephalopathy, N Engl J Med 361:1349-1358, 2009.
Barks JD, Liu YQ, Shangguan Y, et al: Phenobarbital augments hypothermic neuroprotection, Pediatr Res 67:532-537, 2010.
Chau V, Poskitt KJ, Sargent MA, et al: Comparison of computer tomography and magnetic resonance imaging scans on the third day of life in term newborns with neonatal encephalopathy, Pediatrics 123:319-326, 2009.
Corbo ET, Bartnik-Olson BL, Machado S, et al: The effect of whole-body cooling on brain metabolism following perinatal hypoxic-ischemic injury, Pediatr Res 71:85-92, 2012.
Davis AS, Hintz SR, Van Meurs KP, et al: Seizures in extremely low birth weight infants are associated with adverse outcome, J Pediatr 157:720-725, 2010.
De Vries LS, Groenendaal F: Patterns of neonatal hypoxic-ischaemic brain injury, Neuroradiology 52:555-566, 2010.
Douglas-Escobar M, Weiss MD: Hypoxic-ischemic encephalopathy: a review for the clinician, JAMA Pediatr 169:397-403, 2015.
Glass HC, Nash KB, Bonifacio SL, et al: Seizures and magnetic resonance imaging- detected brain injury in newborns cooled for hypoxic-ischemic encephalopathy, J Pediatr 159:731-735, 2011.
Guillet R, Edwards AD, Thoresen M, et al: Seven- to eight-year follow-up of the CoolCap trial of head cooling for neonatal encephalopathy, Pediatr Res 71:205-209, 2012.
Hagberg H, Edwards AD: Groenendall F: perinatal brain damage: the term infant, Neurobiol Dis 92:102-112, 2016.
Hagberg H, Mallard C, Rousset CI, et al: Mitochondria: hub of injury responses in the developing brain, Lancet Neurol 13:217-232, 2014.
Kapadia VS, Chalak LF, DuPont TL, et al: Perinatal asphyxia with hyperoxemia within the first hour of life is associated with moderate to severe hypoxic-ischemic encephalopathy, J Pediatr 163:949-954, 2013.
Laptook AR, Shankaran S, Ambalavanan N, et al: Outcome of term infants using apgar scores at 10 minutes following hypoxic-ischemic encephalopathy, Pediatrics 124:1619-1626, 2009.
Laptook AR, Shankaran S, Tyson JE, et al: Effect of therapeutic hypothermia initiated after 6 hours of age on death or disability among newborns with hypoxic-ischemic encephalopathy: a randomized clinical trial, JAMA 318(16):1550-1560, 2017.
Maitre NL, Smolinsky C, Slaughter JC, et al: Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures, J Perinatol 33:841-846, 2013.
Martinez-Biarge M, Diez-Sebastian J, Kapellou O, et al: Predicting motor outcome and death in term hypoxic-ischemic encephalopathy, Neurology 76:2055-2061, 2011.
Merhar SL, Schibler KR, Sherwin CM, et al: Pharmacokinetics of levetiracetam in neonates with seizures, J Pediatr 159:152-154 e153, 2011.
Murray DM, Boylan GB, Ryan CA, et al: Early EEG findings in hypoxic-ischemic encephalopathy predict outcomes at 2 years, Pediatrics 124:e459-e467, 2009.
Nakagawa TA, Ashwal S, Mathur M, et al: Clinical report. Guidelines for the determination of brain death in infants and children: an update of the 1987 task force recommendations, Pediatrics 128(3):e720-e740, 2011.
Natarajan G, Shankaran S, Saha S, et al: Antecedents and outcomes of abnormal cranial imaging in moderately preterm infants, J Pediatr 2018. [Epub ahead of print]. PMID: 29395186.
Pappas A, Shankaran S, Laptook AR, et al: Hypocarbia and adverse outcome in neonatal hypoxic-ischemic encephalopathy, J Pediatr 158:752-758, 2011.
Rennie JM, Chorley G, Boylan GB, et al: Non-expert use of the cerebral function monitor for neonatal seizure detection, Arch Dis Child Fetal Neonatal Ed F37-F40, 2004.
Sabir H, Jary S, Tooley J, et al: Increased inspired oxygen in the first hours of life is associated with adverse outcome in newborns treated for perinatal asphyxia with therapeutic hypothermia, J Pediatr 161:409-416, 2012.
Sarkar S, Barks JD, Bapuraj JR, et al: Does phenobarbital improve the effectiveness of therapeutic hypothermia in infants with hypoxic-ischemic encephalopathy?, J Perinatol 32:15-20, 2012.
Selewski DT, Jordan BK, Askenzai DJ, et al: Acute kidney injury in asphyxiated newborns treated with therapeutic hypothermia, J Pediatr 162:725-729, 2013.
Shankaran S, Laptook AR, Ehrenkran RA, et al: Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy, N Engl J Med 353:1574-1584, 2005.
Shankaran S, Laptook AR, Pappas A, et al: Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial, JAMA 312:2629-2639, 2014.
Shankaran S, Laptook AR, Tyson JE, et al: Evolution of encephalopathy during whole body hypothermia for neonatal hypoxic-ischemic encephalopathy, J Pediatr 160:567-572, 2012.
Shankaran S, Pappas A, McDonald SA, et al: Childhood outcomes after hypothermia for neonatal encephalopathy, N Engl J Med 366(22):2085-2092, 2012.
Shellhaas RA, Chang T, Tsuchida T, et al: The American clinical neurophysiology Society's guideline on continuous electroencephalography monitoring in neonates, J Clin Neurophysiol 28:611-617, 2011.
Shellhaas RA, Soaita AI, Clancy RR: Sensitivity of amplitude-integrated electroencephalography for neonatal seizure detection, Pediatrics 120:770-777, 2007.
Skranes JH, L0haugen G, Schumacher EM, et al: Amplitude-integrated electroencephalography improves the identification of infants with encephalopathy for therapeutic hypothermia and predicts neurodevelopmental outcomes at 2 years of age, J Pediatr 187:34-42, 2017.
Srinivasakumar P, Zampel J, Wallendorf M, et al: Therapeutic hypothermia in neonatal hypoxic ischemic encephalopathy: electrographic seizures and magnetic resonance imaging evidence of injury, J Pediatr 163:465-470, 2013.
Strohm B, Hobson A, Brocklehurst P, et al: Subcutaneous fat necrosis after moderate therapeutic hypothermia in neonates, Pediatrics 128:e450-e452, 2011.
Tam EWY, Haeusslein LA, Bonifacio SL, et al: Hypoglycemia is associated with increased risk for brain injury and adverse neurodevelopmental outcome in neonates at risk for encephalopathy, J Pediatr 161:88-93, 2012.
Thoresen M, Hellstrom-Westas L, Liu X, et al: Effect of hypothermia on amplitude-integrated electroencephalogram in infants with asphyxia, Pediatrics 126(1):e131-e139, 2010.
Venkatesan C, Young S, Schapiro M, et al: Levetiracetam for the treatment of seizures in neonatal hypoxic ischemic encephalopathy, J Child Neurol 32:210-214, 2017.
Walsh BH, Neil J, Morey J, et al: The frequency and severity of magnetic resonance imaging abnormalities in infants with mild neonatal encephalopathy, J Pediatr 187:26-33, 2017.
Weeke LC, Groenendaal F, Mudigonda K, et al: A novel magnetic resonance imaging score predicts neurodevelopmental outcome after perinatal asphyxia and therapeutic hypothermia, J Pediatr 192:33-40, 2018.
Weeke LC, Groenendaal F, Toet MC, et al: The aetiology of neonatal seizures and the diagnostic contribution of neonatal cerebral magnetic resonance imaging, Dev Med Child Neurol 57:248-256, 2015.
Wu YW, Mathur AM, Chang T, et al: High-dose erythropoietin and hypothermia for hypoxic-ischemic encephalopathy: a phase II trial, Pediatrics 137:2016.
Coulter DM, Zhou H, Rorke-Adams LB: Catastrophic intrauterine spinal cord injury caused by an arteriovenous malformation, J Perinatol 27:186-189, 2007.
D'Amico A, Mercuri E, Tiziano FD, et al: Spinal muscular atrophy, Orphanet J Rare Dis 6:71, 2011.
Mercuri E, Bertini E, Iannaccone ST: Childhood spinal muscular atrophy: controversies and challenges, Lancet Neurol 11:443-452, 2012.
Mills JF, Dargaville PA, Coleman LT, et al: Upper cervical spinal cord injury in neonates: the use of magnetic resonance imaging, J Pediatr 138:105-108, 2001.
Bauer AS, Lucas JF, Heyrani N, et al: Ultrasound screening for posterior shoulder dislocation in infants with persistent brachial plexus birth palsy, J Bone Joint Surg Am 99(9):778-783, 2017.
Brown T, Cupido C, Scarfone H, et al: Developmental apraxia arising from neonatal brachial plexus palsy, Neurology 55:24-30, 2000.
Hoeksma AF, Wolf H, Oei SL: Obstetrical brachial plexus injuries: incidence, natural course and shoulder contracture, Clin Rehabil 14:523-526, 2000.
Jemec B, Grobbelaar AO, Harrison DH: The abnormal nucleus as a cause of congenital facial palsy, Arch Dis Child 83:256-258, 2000.
Murty VS, Ram KD: Phrenic nerve palsy: a rare cause of respiratory distress in newborn, J Pediatr Neurosci 7:225-227, 2012.
Noetzel MJ, Wolpaw JR: Emerging concepts in the pathophysiology of recovery from neonatal brachial plexus injury, Neurology 55:5-6, 2000.
Ridgeway E, Valicenti-McDermott M, Kornhaber L, et al: Effects from birth brachial plexus injury and postural control, J Pediatr 162:1065-1067, 2013.
Stamrood CA, Blok CA, van der Zee DC: Et. al: neonatal phrenic nerve injury due to traumatic delivery, J Perinat Med 37:293-296, 2009.
Strombeck C, Krumlinde-Sundholm L: Forrsberg h: functional outcome at 5 years in children with obstetrical brachial plexus palsy with and without microsurgical reconstruction, Dev Med Child Neurol 42:148-157, 2000.
Van der Holst M, Steenbeek D, Pondaag W, et al: Neonatal brachial plexus palsy in children aged 0 to 2.5 years: parent-perceived family impact, quality of life, and upper extremity functioning, Pediatr Neurol 62:34-42, 2016.
Verzijl H, van der Zwaag B, Lammens M: Et. al: the neuropathology of hereditary congenital facial palsy vs moebius syndrome, Neurology 64:649-653, 2005.
Yang LJS: Neonatal brachial plexus palsy: management and prognostic factors, Semin Perinatol 38:222-234, 2014.
Zuarez-Easton S, Zafran N, Garmi G, et al: Risk factors for persistent disability in children and obstetric brachial plexus palsy, J Perinatol 37:167-171, 2017.
American College of Obstetricians and Gynecologists: Delayed umbilical cord clamping after birth. Committee opinion no 684, Obstet Gynecol 129:e5-e10, 2017.
Boronat N, Aguar M, Rook D, et al: Survival and neurodevelopmental outcomes of preterms resuscitated with different oxygen fractions, Pediatrics 138(6):e20161405, 2016.
Halling C, Sparks JE, Christie L, Wyckoff MH: Efficacy of intravenous endotracheal epinephrine during neonatal cardiopulmonary resuscitation in the delivery room, J Pediatr 185:232-236, 2017.
Hillman N, Kallapur SG, Jobe A: Physiology of transition from intrauterine to extrauterine life, Clin Perinatol 39:769-783, 2012.
Kapadia VS, Lai CV, Kakkilaya V, et al: Impact of the neonatal resuscitation program: recommended low oxygen strategy on outcomes of infants born preterm, J Pediatr 191:35-41, 2017.
Kapadia VS, Wyckoff MH: Drugs during delivery room resuscitation: what, when and why?, Semin Fetal Neonatal Med 18:357-361, 2013.
Laptook AR: Birth asphyxia and hypoxic-ischemic brain injury in the preterm infant, Clin Perinatol 43:529-545, 2016.
Manley BJ, Owen LS, Hooper SB, et al: Towards evidence-based resuscitation of the newborn infant, Lancet 389:1639-1648, 2017.
Oei JL, Saugstad OD, Lei K, et al: Targeted oxygen in the resuscitation of preterm infants, a randomized clinical trial, Pediatrics 139(1):e20161452, 2016.
Perlman J, Kattwinkel J, Wyllie J, et al: Neonatal resuscitation: in pursuit of evidence gaps in knowledge, Resuscitation 83:545-550, 2012.
Perlman JM, Wyllie J, Wyckoff MH, et al: Part 7. Neonatal resuscitation: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations, Circulation 132:S204-S241, 2015.
Saugstad OD: Delivery room management of term and preterm newly born infants, Neonatology 107:365-371, 2015.
Weiner GM, editor: Textbook of neonatal resuscitation, ed 7, Elk Grove Village, IL, 2016, American Academy of Pediatrics.
Wyckoff MH: Initial resuscitation and stabilization of the periviable neonate: the Golden-hour approach, Semin Perinatol 38:12-16, 2014.
American Academy of Pediatrics Committee on Fetus and Newborn: Apnea of prematurity, Pediatrics 137(1):e20153757, 2016.
Arad-Cohen N, Cohen A, Tirosh E: The relationship between gastroesophageal reflux and apnea in infants, J Pediatr 137:321-326, 2000.
Henderson-Smart DJ: The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies, Aust Paediatr J 17:273-276, 1981.
Herlenius E, Kuhn P: Sudden unexpected postnatal collapse of newborn infants: a review of cases, definitions, risks, and preventive measures, Transl Stroke Res 4:236-247, 2013.
Levin JC, Jang J, Rhein LM: Apnea in the otherwise healthy, term newborn: national prevalence and utilization during the birth hospitalization, J Pediatr 181:67-73, 2017.
Ramanathan R, Corwin MJ, Hunt CE, et al; Collaborative Home Infant Monitoring
Evaluation (CHIME) Study Group: Cardiorespiratory events recorded on home monitors: comparison of healthy infants with those at increased risk for SIDS, JAMA 285:2199-2207, 2001.
Schmidt B, Anderson PJ, Doyle LW, et al: Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity, JAMA 307:275-282, 2012.
Schmidt B, Roberts RS, Davis P, et al: Caffeine therapy for apnea of prematurity, N Engl J Med 354:2112-2121, 2006.
Shah MD, Dookeran KA, Khan JY: Clinical outcomes associated with a failed infant car seat challenge, J Pediatr 180:130-140, 2017.
Steer P, Flenady V, Shearman A, et al: High dose caffeine citrate for extubation of preterm infants: a randomized controlled trial, Arch Dis Child Fetal Neonatal Ed 89:F499-F503, 2004.
Wheatley E, Kennedy KA: Crossover trial of treatment for bradycardia attributed to gastroesophageal reflux in preterm infants, J Pediatr 155:516-5201, 2009.
American Academy of Pediatrics Committee on Fetus and Newborn: Policy statement—postnatal corticosteroids to prevent or great bronchopulmonary dysplasia, Pediatrics 126:800-808, 2010.
American Academy of Pediatrics Committee on Fetus and Newborn: Policy statement— surfactant replacement therapy for preterm and term neonates with respiratory distress, Pediatrics 133:156-163, 2014.
American Academy of Pediatrics Committee on Fetus and Newborn: Policy statement—respiratory support in preterm infants at birth, Pediatrics 133:171-174, 2014.
American College of Obstetricians and Gynecologists: Committee opinion—antenatal corticosteroid therapy for fetal maturation, Obstet Gynecol 128:e187-e194, 2016.
Anderson CC, Hodyl NA, Kirpalani HM, Stark MJ: A theoretical and practical approach to defining “adequate oxygenation” in the preterm infant, Pediatrics 139(4):e20161117, 2017.
Bancalari E, Claure N: Oxygen targets and outcomes in premature infants, JAMA 309:2161-2162, 2013.
Batton B, Zhu X, Fanaroff J, et al: Blood pressure, anti-hypotensive therapy, and neurodevelopment in extremely preterm infants, J Pediatr 154:351-357, 2009.
Baud O, Maury L, Lebail F, et al: Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMИЛOC): a double-blind, placebo-controlled, multicenter, randomized trial, Lancet 387: 1827-1836, 2016.
Been JV, Kornelisse RF, Rours IG, et al: Early postnatal blood pressure in preterm infants: effects of chorioamnionitis and timing of antenatal steroids, Pediatr Res 66:571-576, 2009.
Bishop NB, Stankiewicz P, Steinhorn RH: Alveolar capillary dysplasia, Am J Respir Crit Care Med 184:172-179, 2011.
Boost II United Kingdom, Australia, and New Zealand Collaborative Groups: Oxygen saturation and outcomes in preterm infants, N Engl J Med 368:2094-2104, 2013.
Brownfoot FC, Gagliardi DI, Bain E, et al: Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth, Cochrane Database Syst Rev (8):CD006764, 2013.
Carlo WA, McDonald SA, Fanaroff AA, et al: Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation, JAMA 306:2348-2358, 2011.
Cole FS, Alleyne C, Barks JDE, et al: NIH consensus development Conference statement: inhaled nitric-oxide therapy for premature infants, Pediatrics 127:363-369, 2011.
Donohue PK, Gilmore MM, Cristofalo E, et al: Inhaled nitric oxide in preterm infants: a systematic review, Pediatrics 127:e414-e422, 2011.
Doyle LW, Ehrenkranz RA, Halliday HL: Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants, Cochrane Database Syst Rev (5):CD001145, 2014.
Doyle LW, Ehrenkranz RA, Halliday HL: Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev (5):CD001146, 2014.
Dunn MS, Kaempf J, deKlerk A, et al: Randomized trial comparing three approaches to the initial respiratory management of preterm neonates, Pediatrics 128:1069-1076, 2011.
Fischer HS: Buhrer C: avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis, Pediatrics 132:e1351-e1360, 2013.
Gopel W, Kribs A, Ziegler A, et al: Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomized, controlled trial, Lancet 378:1627-1634, 2011.
Greenough A, Rossor TE, Sundaresan A, et al: Synchronized mechanical ventilation for respiratory support in newborn infants, Cochrane Database Syst Rev (9):CD000456, 2016.
Gyamfi-Bannerman C, Blackwell TSC, Tita ATN, et al: Antenatal betamethasone for women at risk for late preterm delivery, N Engl J Med 374(14):1311-1320, 2016.
Hamvas A, Cole FS, Nogee LM: Genetic disorders of surfactant proteins, Neonatology 91:311-317, 2007.
Hosono S, Mugishima H, Fujita H, et al: Blood pressure and urine output during the first 120 h of life in infants born at less than 29 weeks' gestation related to umbilical cord milking, Arch Dis Child Fetal Neonatal Ed 94:F328-F331, 2009.
Huang L, Roberts CT, Manley BJ, et al: Cost-effectiveness analysis of nasal continuous positive airway pressure versus nasal high flow therapy as primary support for infants born preterm, J Pediatr 196:58-64, 2018.
Isayama T, et al: Association of noninvasive ventilation strategies with mortality and bronchopulmonary dysplasia among preterm infants: a systematic review and meta-analysis, JAMA 316:611-624, 2016.
Kelly BA, Lewandowski AJ, Worton SA, et al: Antenatal glucocorticoid exposure and long-term alterations in aortic function and glucose metabolism, Pediatrics 129:e1282-e1290, 2012.
Manja V, Lakshminrusimha S, Cook DJ: Oxygen saturation target range for extremely preterm infants: a systematic review and meta-analysis, JAMA Pediatr 169:332-340, 2015.
Meneses J, Bhandari V, Alves JG, et al: Noninvasive ventilation for respiratory distress syndrome: a randomized controlled trial, Pediatrics 127:300-307, 2011.
Morley CJ, Davis PG, Doyle LW, et al: Nasal CPAP or intubation at birth for very preterm infants, N Engl J Med 358:700-708, 2008.
Ng PC, Lee CH, Bnur FL, et al: A double-blind, randomized, controlled study of a “stress dose” of hydrocortisone for rescue treatment of refractory hypotension in preterm infants, Pediatrics 117:367-375, 2006.
Owen LS, Manley BJ, Davis PG, Doyle LW: The evolution of modern respiratory care for preterm infants, Lancet 389:1649-1658, 2017.
Polin RA, Bateman D: Oxygen-saturation targets in preterm infants, N Engl J Med 368:2141-2142, 2013.
Sandri F, Plavka R, Ancora G, et al: Prophylactic or early selective surfactant combined with nCPAP in very preterm infants, Pediatrics 125:e1402-e1409, 2010.
Schmidt B, Whyte RK, Asztalos EV, et al: Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants, JAMA 309:2111-2120, 2013.
Schmidt B, Whyte RK, Roberts RS: Oxygen targeting in infants born extremely preterm who are small for gestational age: a need for heightened vigilance, J Pediatr 186:9-10, 2017.
Schmolzer GM, Kuma M, Pichler G, et al: Non-invasive versus respiratory support in preterm infants in the delivery room; systematic review and meta-analysis, BMJ 342:d1696, 2011.
Shah SS, Ohlsson A, Halliday H, et al: Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates, Cochrane Database Syst Rev (5):CD001969, 2017.
Shah SS, Ohlsson A, Halliday H, et al: Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants, Cochrane Database Syst Rev (5):CD002057, 2012.
Shah SS, Ohlsson A, Halliday H, et al: Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm infants, Cochrane Database Syst Rev (5):CD002058, 2012.
Singh N, Halliday HL, Stevens TP, et al: Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants, Cochrane Database Syst Rev (12):CD010249, 2015.
Stalnacke J, Heijtz RD, Norberg H, et al: Cognitive outcome in adolescents and young adults after repeat courses of antenatal corticosteroids, J Pediatr 163:441-446, 2013.
Subramaniam P, Ho JJ, Davis PG: Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants, Cochrane Database Syst Rev (6):CD001243, 2016.
SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network: Early CPAP versus surfactant in extremely preterm infants, N Engl J Med 362:1970-1978, 2010.
SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Carlo WA, Finer NN, et al: Target ranges of oxygen saturation in extremely preterm infants, N Engl J Med 362:1959-1969, 2010.
Taha DK, Kornhauser M, Greenspan JS, et al: High flow nasal cannula use is associated with increased morbidity and length of hospitalization in extremely low birth weight infants, J Pediatr 173:50-55, 2016.
Vaucher YE, Peralta-Carcelen M, Finer NN, et al: Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial, N Engl J Med 367:2495-2504, 2012.
Venkataraman R, Kamaluddeen M, Hasan SU, et al: Intratracheal administration of budesonide-surfactant in prevention of bronchopulmonary dysplasia in very low birth weight infants: a systematic review and meta-analysis, Pediatr Pulmonol 52:2017. Vellanki H, Antunes M, Locke RG, et al: Decreased incidence of pneumothorax in VLBW infants after increased monitoring of tidal volumes, Pediatrics 130:e1352-e1358, 2012. Wilkinson D, Andersen C, O'Donnell CP, et al: High flow nasal cannula for respiratory support in preterm infants, Cochrane Database Syst Rev (2):CD006405, 2016.
Wright CJ, Polin RA, Kirpalani H: Continuous positive airway pressure to prevent neonatal lung injury: how did we get here, and how do we improve?, J Pediatr 173:17-24, 2016.
Yeh TF, Chen CM, Wu SY, et al: Intratracheal administration of budesonide/surfactant to prevent bronchopulmonary dysplasia, Am J Respir Crit Care Med 193:86-95, 2016.
Abman SH, Collaco JM, Shepherd EG, et al; Bronchopulmonary Dysplasia Collaborative: Interdisciplinary care of children with severe bronchopulmonary dysplasia, J Pediatr 181:12-28, 2017.
Ahlfeld SK, Conway SJ: Assessment of inhibited alveolar-capillary membrane structural development and function in bronchopulmonary dysplasia, Birth Defects Res A Clin Mol Teratol 100:168-179, 2014.
American Academy of Pediatrics Committee on Fetus and Newborn: Policy statement—postnatal corticosteroids to prevent or great bronchopulmonary dysplasia, Pediatrics 126:800-808, 2010.
American Academy of Pediatrics Committee on Fetus and Newborn: Policy statement— surfactant replacement therapy for preterm and term neonates with respiratory distress, Pediatrics 133:156-163, 2014.
American Academy of Pediatrics Committee on Fetus and Newborn: Policy statement—respiratory support in preterm infants at birth, Pediatrics 133:171-174, 2014.
Bancalari E, Claure N: Oxygen targets and outcomes in premature infants, JAMA 309:2161-2162, 2013.
Barrington KJ, Fortin-Pellerin E, Pennaforte T: Fluid restriction for treatment of preterm infants with chronic lung disease, Cochrane Database Syst Rev (2):CD005389, 2017.
Bassler D, Plavka R, Shinwell ES, et al; NEUROSIS Trial Group: Early inhaled budesonide for the prevention of bronchopulmonary dysplasia, N Engl J Med 373:1497-1506, 2015.
Bassler D, Shinwell ES, Hallman M, et al: Long-term effects of inhaled budesonide for bronchopulmonary dysplasia, N Engl J Med 378(2):148-156, 2018.
Baud O, Maury L, Lebail F, et al; PREMИЛOC Trial Study Group: Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMИЛOC): a double-blind, placebo-controlled, multicentre, randomised trial, Lancet 387:1827-1836, 2016.
Baud O, Trousson C, Biran V, et al: Association between early low-dose hydrocortisone therapy in extremely preterm neonates and neurodevelopmental outcomes at 2 years of age, JAMA 317(13):1329-1337, 2017.
Beam KS, Aliaga S, Ahlfeld SK, et al: A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants, J Perinatol 34:705-710, 2014.
Benders MJNL, Groenendaal F, Van Bel F, et al: Brain development of the preterm neonate after neonatal hydrocortisone treatment for chronic lung disease, Pediatr Res 66:555-559, 2009.
Clyman RI: The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia, Semin Perinatol 37:102-107, 2013.
Cole FS, Alleyne C, Barks JDE, et al: NIH consensus development Conference statement: inhaled nitric-oxide therapy for premature infants, Pediatrics 127:363-369, 2011.
Cristea AI, Carroll AE, Davis SD, et al: Outcomes of children with severe bronchopulmonary dysplasia who were ventilator dependent at home, Pediatrics 132:e727-e734, 2013.
Darlow BA, Graham PJ, Rojas-Reyes MX: Vitamin a supplementation to prevent mortality and short and long-term morbidity in very low birth weight infants, Cochrane Database Syst Rev (8):CD000501, 2016.
Donohue PK, Gilmore MM, Cristofalo E, et al: Inhaled nitric oxide in preterm infants: a systematic review, Pediatrics 127:e414-e422, 2011.
Doyle LW, Carse E, Adams AM, et al: Ventilation in extremely preterm infants and respiratory function at 8 years, N Engl J Med 377(4):329-337, 2017.
Doyle LW, Ehrenkranz RA, Halliday HL: Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants, Cochrane Database Syst Rev (5):CD001145, 2014.
Doyle LW, Ehrenkranz RA, Halliday HL: Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev (5):CD001146, 2014.
Dunn MS, Kaempf J, deKlerk A, et al: Randomized trial comparing three approaches to the initial respiratory management of preterm neonates, Pediatrics 128:1069-1076, 2011.
Fischer HS: Buhrer C: avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis, Pediatrics 132:e1351-e1360, 2013.
Gibson AM, Doyle LW: Respiratory outcomes for the tiniest or most immature infants, Semin Fetal Neonatal Med 19:105-111, 2014.
Gopel W, Kribs A, Ziegler A, et al: Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomized, controlled trial, Lancet 378:1627-1634, 2011.
Gough A, Spence D, Linden M, et al: General and respiratory health outcomes in adult survivors of bronchopulmonary dysplasia: a systematic review, Chest 141:1554-1567, 2012.
Higgins RD, Jobe AH, Koso-Thomas M, et al: Bronchopulmonary dysplasia: executive summary of a workshop, J Pediatr 197:300-308, 2018.
Inatomi T, Oue S, Ogihara T, et al: Antenatal exposure to urea plasma species exacerbates bronchopulmonary dysplasia synergistically with subsequent prolonged mechanical ventilation in preterm infants, Pediatr Res 71:267-273, 2012.
Isayama T, et al: Association of noninvasive ventilation strategies with mortality and bronchopulmonary dysplasia among preterm infants: a systematic review and meta-analysis, JAMA 316:611-624, 2016.
Islam JY, Keller RL, Aschner JL, et al: Understanding the short- and long-term respiratory outcomes of prematurity and bronchopulmonary dysplasia, Am J Respir Crit Care Med 192:143-156, 2015.
Jobe AH, Steinhorn R: Can we define bronchopulmonary dysplasia?, J Pediatr 188:19-23, 2017.
Kinsella JP, Cutter GR, Walsh WF, et al: Early inhaled nitric oxide therapy in premature newborns with respiratory failure, N Engl J Med 355:354-364, 2006.
Krishnan U, Feinstein JA, Adatia I, et al: Evaluation and management of pulmonary hypertension in children with bronchopulmonary dysplasia, J Pediatr 188:24-34, 2017.
Laughon M, Bose C, Allred EN, et al: Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants, Arch Dis Child Fetal Neonatal Ed 96:F114-F120, 2011.
Lum S, Kirkby J, Welsh L, et al; EPICure Study Group: Nature and severity of lung function abnormalities in extremely preterm children at 11 years of age, Eur Respir J 37:1199-1207, 2011.
Manja V, Lakshminrusimha S, Cook DJ: Oxygen saturation target range for extremely preterm infants: a systematic review and meta-analysis, JAMA Pediatr 169:332-340, 2015.
Manley BJ, Owen LS, Doyle LW, et al: High-flow nasal cannulae in very preterm infants after extubation, N Engl J Med 369:1425-1433, 2013.
Meneses J, Bhandari V, Alves JG, et al: Noninvasive ventilation for respiratory distress syndrome: a randomized controlled trial, Pediatrics 127:300-307, 2011.
Mercier JC, Hummler H, Durrmeyer X, et al: Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomized controlled trial, Lancet 376:346-352, 2010.
Sandri F, Plavka R, Ancora G, et al: Prophylactic or early selective surfactant combined with nCPAP in very preterm infants, Pediatrics 125:e1402-e1409, 2010.
Schmolzer GM, Kuma M, Pichler G, et al: Non-invasive versus respiratory support in preterm infants in the delivery room; systematic review and meta-analysis, BMJ 342:d1696, 2011.
Schmolzer GM, Te Pas AB, Davis PG, et al: Reducing lung injury during neonatal resuscitation of preterm infants, J Pediatr 153:741-745, 2008.
Shah SS, Ohlsson A, Halliday H, et al: Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates, Cochrane Database Syst Rev (5):CD001969, 2017.
Shah SS, Ohlsson A, Halliday H, et al: Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants, Cochrane Database Syst Rev (5):CD002057, 2012.
Shah SS, Ohlsson A, Halliday H, et al: Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm infants, Cochrane Database Syst Rev (5):CD002058, 2012.
Singh N, Halliday HL, Stevens TP, et al: Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants, Cochrane Database Syst Rev (12):CD010249, 2015.
Stark AR, Carlo WA, Tyson JE, et al: Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants, N Engl J Med 344:95-101, 2001.
Steinhorn R, Davis JM, Gopel W, et al: Chronic pulmonary insufficiency of prematurity: developing optimal endpoints for drug development, J Pediatr 191:15-21, 2017.
Stevens TP, Blennow M, Myers EH, et al: Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome, Cochrane Database Syst Rev (4):CD003063, 2007.
Stewart A, Brion LP: Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease, Cochrane Database Syst Rev (9):CD001453, 2011.
Subramaniam P, Ho JJ, Davis PG: Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants, Cochrane Database Syst Rev (6):CD001243, 2016.
SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network: Early CPAP versus surfactant in extremely preterm infants, N Engl J Med 362:1970-1978, 2010.
SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Carlo WA, Finer NN, et al: Target ranges of oxygen saturation in extremely preterm infants, N Engl J Med 362:1959-1969, 2010.
Thebaud B, Kourembanas S: Can we cure bronchopulmonary dysplasia?, J Pediatr 191:12-14, 2017.
Vaucher YE, Peralta-Carcelen M, Finer NN, et al: Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial, N Engl J Med 367:2495-2504, 2012.
Venkataraman R, Kamaluddeen M, Hasan SU, et al: Intratracheal administration of budesonide-surfactant in prevention of bronchopulmonary dysplasia in very low birth weight infants: a systematic review and meta-analysis, Pediatr Pulmonol 52:2017.
Watterberg KL, Gerdes JS, Cole CH, et al: Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial, Pediatrics 114:1649-1657, 2004.
Wheeler K, Klingenberg C, McCallion N, et al: Volume-targeted versus pressure-limited ventilation in the neonate, Cochrane Database Syst Rev (3):CD003666, 2005.
Wilkinson D, Andersen C, O'Donnell CP, et al: High flow nasal cannula for respiratory support in preterm infants, Cochrane Database Syst Rev (2):CD006405, 2016.
Wright CJ, Polin RA, Kirpalani H: Continuous positive airway pressure to prevent neonatal lung injury: how did we get here, and how do we improve?, J Pediatr 173:17-24, 2016.
Yeh TF, Chen CM, Wu SY, et al: Intratracheal administration of budesonide/surfactant to prevent bronchopulmonary dysplasia, Am J Respir Crit Care Med 193:86-95, 2016.
Benitz WE, AAP Committee on Fetus and Newborn: Patent ductus arteriosus in preterm infants, Pediatrics 137(1):e20153730, 2016.
Clyman RI, Couto J, Murphy GM: Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Semin Perinatol 36:123-129, 2012.
Clyman R, Wickremasinghe A, Jhaveri N, et al: Enteral feeding during indomethacin and ibuprofen treatment of a patent ductus arteriosus, J Pediatr 163:406-411, 2013.
Clyman RI: The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia, Semin Perinatol 37:102-107, 2013.
De Buyst J, Rakza T, Pennaforte T, et al: Hemodynamic effects of fluid restriction in preterm infants with significant patent ductus arteriosus, J Pediatr 161:404-408, 2012.
Doyle LW, Ehrenkranz RA, Halliday HL: Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants, Cochrane Database Syst Rev (5):CD001145, 2014.
Doyle LW, Ehrenkranz RA, Halliday HL: Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev (5):CD001146, 2014.
El-Khuffash AF, Jain A, McNamara PJ: Ligation of the patent ductus arteriosus in preterm infants: understanding the physiology, J Pediatr 162:1100-1106, 2013.
Harkin P, Harma A, Aikio O, et al: Paracetamol accelerates closure of the ductus arteriosus after premature birth: a randomized trial, J Pediatr 177:72-77, 2016.
Jain A, Shah PS: Diagnosis, evaluation, and management of patent ductus arteriosus in preterm neonates, JAMA Pediatr 169:863-872, 2015.
Kim SY, Shin SH, Kim HS, et al: Pulmonary arterial hypertension after ibuprofen treatment for patent ductus arteriosus in very low birth weight infants, J Pediatr 179:49-53, 2016.
Liebowitz M, Clyman RI: Prophylactic indomethacin compared with delayed conservative management of the patent ductus arteriosus in extremely preterm infants: effects on neonatal outcomes, J Pediatr 187:119-126, 2017.
Liebowitz M, Koo J, Wickrenasinghe A, et al: Effects of prophylactic indomethacin on vasopressor-dependent hypotension in extremely preterm infants, J Pediatr 182:21-27, 2017.
Louis D, Torgalkar R, Shah J, et al: Enteral feeding during indomethacin treatment for patent ductus arteriosus: association with gastrointestinal outcomes, J Perinatol 36:544-548, 2016.
Luecke CM, Liviskie CJ, Zeller BN, et al: Acetaminophen for patent ductus arteriosus in extremely low-birth-weight neonates, J Pediatr Pharmacol Ther 22(6):461-466, 2017.
Ngo S, Profit J, Gould JB, Lee HC: Trends in patent ductus arteriosus diagnosis and management for very low birth weight infants, Pediatrics 138(4):e20162390, 2017.
Ohlsson A, Shah PS: Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants, Cochrane Database Syst Rev (3):CD010061, 2015.
Ohlsson A, Walia R, Shah SS: Ibuprofen for the treatment of patent ductus arteriosus inpreterm or low birth weight (or both) infants, Cochrane Database Syst Rev (2):CD003481, 2015.
Roze JC, Cambonie G, Marchand-Martin L, et al: Association between early screening for patent ductus arteriosus and in-hospital mortality among extremely preterm infants, JAMA 313(24):2441-2448, 2015.
Semberova J, Sirc J, Miletin J, et al: Spontaneous closure of patent ductus arteriosus in infants <1500 g, Pediatrics 140(2):e20164258, 2017.
Sivanandan S, Agarwal R: Pharmacological closure of patent ductus arteriosus: selecting the agent and route of administration, Paediatr Drugs 18:123-138, 2016.
Sosenko IRS, Fajardo F, Claure N, et al: Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial, J Pediatr 160:929-935, 2012.
Wickremasinghe AC, Rogers EE, Piecuch RE, et al: Neurodevelopmental outcomes following two different treatment approaches (early ligation and selective ligations) for patent ductus arteriosus, J Pediatr 161:1065-1072, 2012.
Liem JJ, Huq SI, Ekuma O, et al: Transient tachypnea of the newborn may be an early clinical manifestation of wheezing symptoms, J Pediatr 151:29-33, 2007.
Moresco L, Bruschettini M, Cohen A, et al: Salbutamol for transient tachypnea of the newborn, Cochrane Database Syst Rev (5):CD011878, 2016.
Pramanik AK, Rangaswamy N, Gates T: Neonatal respiratory distress: a practical approach to its diagnosis and management, Pediabr CUn North Am 6M53-469, 2015.
Chettri S, Adhisivam B, Bhat BV: Endotracheal suction for nonvigorous neonates born through meconium stained amniotic fluid: a randomized controlled trial, J Pediatr 166:1208-1213, 2015.
Natarajan CK, Sankar MJ, Jain K, et al: Surfactant therapy and antibiotics in neonates with meconium aspiration syndrome: a systematic review and meta-analysis, J Perinatol 36:S49-S54, 2016.
Vain NE, Szyld EG, Prudent LM: Oropharyngeal and nasopharyngeal suctioning of meconium-stained neonates before delivery of their shoulders: multicentre, randomized controlled trial, Lancet 364:597-602, 2004.
Wiswell TE, Gannon CM, Jacob J, et al: Delivery room management of the apparently vigorous meconium-stained neonate: results of the multicenter, international collaborative trial, Pediatrics 105:1-7, 2000.
Wyckoff MH, Aziz K, Escobedo MB, et al: Part 13. Neonatal resuscitation: 2015 American heart association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care, Circulation 132:S543-S560, 2015.
Backes CH, Nealon E, Armstrong AK, et al: Pulmonary vein stenosis in infants: a systematic review, meta-analysis, and meta-regression, J Pediatr 198:36-45, 2018.
Baquero H, Soliz A, Neira F, et al: Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study, Pediatrics 117:1077-1083, 2006.
Barrington KJ, Finer N, Pennaforte T: Inhaled nitric oxide for respiratory failure in preterm infants, Cochrane Database Syst Rev (1):CD000509, 2017.
Bishop NB, Stankiewicz P, Steinhorn RH: Alveolar capillary dysplasia, Am J Respir Crit Care Med 184:172-179, 2011.
Finer N, Barrington KJ, Pennaforte T, et al: Nitric oxide for respiratory failure in infants born at or near term, Cochrane Database Syst Rev (1):CD000399, 2017.
Ibrahim YI, Ninnis JR, Hopper AO, et al: Inhaled nitric oxide therapy increases blood nitrite, nitrate, and S-nitrosohemoglobin concentrations in infants with pulmonary hypertension, J Pediatr 160:245-251, 2012.
Kieler H, Artama M, Engeland A, et al: Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five nordic countries, BMJ 344:d8012, 2012.
Kulik TJ, Rhein LM, Mullen MP: Pulmonary arterial hypertension in infants with chronic lung disease: will we ever understand it?, J Pediatr 157(2):186-190, 2010.
Lakshminrusimha S, Shankaran S, Laptook A, et al: Pulmonary hypertension associated with hypoxic-ischemic encephalopathy: antecedent characteristics and comorbidities, J Pediatr 196:45-51, 2018.
Sawyer T, Antle A, Studer M, et al: Neonatal pulmonary artery thrombosis presenting as persistent pulmonary hypertension of the newborn, Pediatr Cardiol 30:520-522, 2009.
Sen P, Thakur N, Stockton DW, et al: Expanding the phenotype of alveolar capillary dysplasia (ACD), J Pediatr 145:646-651, 2004.
Steinhorn RH, Kinsella JP, Pierce C, et al: Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension, J Pediatr 155:841-847, 2009.
Belfort MA, Olutoye OO, Cass DL, et al: Feasibility and outcomes of fetoscopic tracheal occlusion for severe left diaphragmatic hernia, Obstet Gynecol 129:20-29, 2017.
Deeney S, Howley LW, Hodges M, et al: Impact of objective echocardiographic criteria for timing of congenital diaphragmatic hernia repair, J Pediatr 192:99-104, 2018.
Golden J, James N, Zagory J, et al: Outcomes of congenital diaphragmatic hernia repair on extracorporeal life support, Pediatr Surg Int 33:125-131, 2017.
Harrison MR, Keller RL, Hawgood SB, et al: A randomized trial of fetal endoscopic tracheal occlusion for severe congenital diaphragmatic hernia, N Engl J Med 349:1916-1924, 2003.
Jaillard SM, Pierrat V, Dubois A, et al: Outcome at two years of infants with congenital diaphragmatic hernia: a population-based study, Ann Thorac Surg 75:250-256, 2003.
Kays DW, Talbert JL, Islam S, et al: Improved survival in left liver-up congenital diaphragmatic hernia by early repair before extracorporeal membrane oxygenation: optimization of patient selection by multivariate risk modeling, J Am Coll Surg 222(4):459-470, 2016.
Keszler M: Congenital diaphragmatic hernia: not quite there yet, J Pediatr 163:15-16, 2013.
Konduri GG, Vohr B, Robertson C, et al: Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up, J Pediatr 150:235-240, 2007.
Lee TC, Lim FY, Keswani SG, et al: Late gestation fetal magnetic resonance imaging- derived total lung volume predicts postnatal survival and need for extracorporeal membrane oxygenation support in isolated congenital diaphragmatic hernia, J Pediatr Surg 46:1165-1171, 2011.
Logan JW, Rice HE, Goldberg RN, et al: Congenital diaphragmatic hernia: a systematic review and summary of best-evidence practice strategies, J Perinatol 27:535-549, 2007.
Menon SC, Tani LY, Weng HY, et al; Congenital Diaphragmatic Hernia Study Group: Clinical characteristics and outcomes of patients with cardiac defects and congenital diaphragmatic hernia, J Pediatr 162:114-119, 2013.
Olson E, Lusk LA, Fineman JR, et al: Short-term treprostinil use in infants with congenital diaphragmatic hernia following repair, J Pediatr 167:762-764, 2015.
Puligandla PS, Grabowski J, Austin M, et al: Management of congenital diaphragmatic hernia: a systematic review from the APSA outcomes and evidence based practice committee, J Pediatr Surg 50:1958-1970, 2015.
Putnam LR, Harting MT, Tsao K, Congenital Diaphragmatic Hernia Study Group: Congenital diaphragmatic hernia: defect size and infant morbidity at discharge, Pediatrics 138:e20162043, 2016.
Rollins MD: Recent advances in the management of congenital diaphragmatic hernia, Curr Opin Pediatr 24:379-385, 2012.
Snoek KG, Capolupo I, van Rosmalen J, CDH EURO Consortium: Conventional mechanical ventilation versus high-frequency oscillatory ventilation for congenital diaphragmatic hernia: a randomized clinical trial (the VICI-trial), Ann Surg 263:867-874, 2016.
Turek JW, Nellis JR, Sherwood BG, et al: Shifting risks and conflicting outcomes: ECMO for neonates with congenital diaphragmatic hernia in the modern era, J Pediatr 190:163-168, 2017.
Cao GQ, Tang ST, Aubdoolah TH, et al: Laparoscopic diaphragmatic hemiplication in children with acquired diaphragmatic eventration after congenital heart surgery, J Laparoendosc Adv Surg Tech A 25:852-857, 2015.
Hu J, Wu Y, Wang J, et al: Thoracoscopic and laparoscopic plication of the hemi- diaphragmis effective in the management of diaphragmatic eventration, Pediatr Surg Int 30:19-24, 2014.
Wat MJ, Veenma D, Hogue J, et al: Genomic alterations that contribute to the development of isolated and non-isolated congenital diaphragmatic hernia, J Med Genet 48:299-307, 2011.
Wu S, Zang N, Zhu J, et al: Congenital diaphragmatic eventration in children: 12 years' experience with 177 cases in a single institution, J Pediatr Surg 50:1088-1092, 2015.
De Waal K, Kluckow M: Prolonged rupture of membranes and pulmonary hypoplasia in very preterm infants: pathophysiology and guided treatment, J Pediatr 166(5):1113-1120, 2015.
Litmanovitz I, Carlo WA: Expectant management of pneumothorax in ventilated neonates, Pediatrics 122:e975-e979, 2008.
Watkinson M, Tiron I: Events before the diagnosis of a pneumothorax in ventilated neonates, Arch Dis Child Fetal Neonatal Ed 85:F201-F203, 2001.
Alfaleh K, Smyth JA, Roberts RS, et al: Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms, Pediatrics 121:e233-e238, 2008.
Scholl JE, Yanowitz TD: Pulmonary hemorrhage in very low birth weight infants: a case-control analysis, J Pediatr 166(4):1083-1084, 2015.
Cuenca A.G., et al: Pulling the plug — management of meconium plug syndrome in neonates, J Surg Res 175(2):e43-e46, 2012.
Del Ciampo I.R., et al: [Early manifestations of cystic fibrosis in a premature patient with complex meconium ileus at birth], Rev Paul Pediatr 33(2):241-245, 2015.
Eckoldt F., et al: Meconium peritonitis and pseudo-cyst formation: prenatal diagnosis and post-natal course, Prenat Diagn 23(11):904-908, 2003.
Egic A., et al: [Prenatal diagnosis of meconium ileus and meconium peritonitis: indications for cystic fibrosis testing], Srp Arh Celok Lek 139(7-8):527-530, 2011.
Farrell P.M., et al: Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation, J Pediatr 181:S4-S15.e1, 2017.
Karimi A., et al: Issues in the management of simple and complex meconium ileus, Pediatr Surg Int 27(9):963-968, 2011.
Sabetay C., et al: [Clinical and therapeutical considerations regarding the diagnosis and treatment in meconial disease], Chirurgia (Bucur) 105(1):67-70, 2010.
Tsai M.H., et al: Clinical manifestations in infants with symptomatic meconium peritonitis, Pediatr Neonatol 50(2):59-64, 2009.
Abrahamsson TR: Not all probiotic strains prevent necrotizing entercolitis in premature infants, Lancet 387:624-625, 2016.
Cacho NT, Parker LA, Neu J: Necrotizing enterocolitis and human milk feeding: a systemic review, Clin Perinatol 44:49-67, 2017.
Cuna A, Sampath V: Genetic alterations in necrotizing enterocolitis, Semin Perinatol 41:61-69, 2017.
Fasano A: Gut microbiome and necrotizing enterocolitis: time for intervention?, Lancet 387:1884-1885, 2016.
Frost BL, Modi BP, Jaksic T, et al: New medical and surgical insights into neonatal necrotizing enterocolitis: a review, JAMA Pediatr 171(1):83-88, 2017.
Gilfillan M, Bhandari V, clinical practice guidelines: Biomarkers for the diagnosis of neonatal sepsis and necrotizing enterocolitis, Early Hum Dev 105:25-33, 2017.
Hull MA, Fisher JG, Gutierrez IM, et al: Mortality and management of surgical necrotizing enterocolitis in very low birth weight neonates: a prospective cohort study, J Am Coll Surg 218:1148-1155, 2014.
Kantorowska A, Wei JC, Cohen RS, et al: Impact of donor milk availability on breast milk use and necrotizing enterocolitis rates, Pediatrics 137(1):e20153123, 2016.
Martin VJ, Leonard MM, Fiechtner L, Fasano A: Transitioning from descriptive to mechanistic understanding of the microbiome: the need for a prospective longitudinal approach to predicting disease, J Pediatr 179:240-248, 2016.
Nakayuenyongsuk W, Christofferson M, Stevenson DK, et al: Point-of-care fecal calprotectin monitoring in preterm infants at risk for necrotizing enterocolitis, J Pediatr 196:98-103, 2018.
National Institute of Child Health and Human Development (NICHD): National center for research resources (NCRR): laparotomy vs. drainage for infants with necrotizing enterocolitis (NEST), Bethesda, MD, 2009, National Library of Medicine. cited 2017. http://clinicaltrials.gov/show/NCT01029353.
Nino DF, Sodhi CP, Hackam DJ: Necrotizing enterocolitis: new insights into pathogenesis and mechanisms, Nat Rev Gastroenterol Hepatol 13(10):590-600, 2016.
Raval MV, Hall NJ, Pierro A, et al: Evidence-based prevention and surgical treatment of necrotizing enterocolitis: a review of randomized controlled trials, Semin Pediatr Surg 22:117-121, 2013.
Rusconi B, Warner BB: The hidden treasure of neonatal screening: identifying new risk factors and possible mechanism of necrotizing enterocolitis through big data, J Pediatr 181:9-11, 2017.
Shah BA, Migliori A, Kurihara I, et al: Blood level of inter-alpha inhibitor proteins distinguished necrotizing entercolitis from spontaneous intestinal perforation, J Pediatr 180:135-140, 2017.
Sylvester KG, Kastenberg ZJ, Moss RL, et al: Acylcarnitine profiles reflect metabolic vulnerability for necrotizing enterocolitis in newborns born premature, J Pediatr 181:80-85, 2017.
Tam PKH, Chung PHY, St Peter SD, et al: Advances in paediatric gastroenterology, Lancet 390:1072-1082, 2017.
Underwood MA: Impact of probiotics on necrotizing enterocolitis, Semin Perinatol 41:41-51, 2017.
Warner BB, Deych E, Zhou Y, et al: Gut bacteria dysbiosis and necrotizing enterocolitis in very low birthweight infants: a prospective case-control study, Lancet 387:1928-1936, 2016.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation, Pediatrics 114:297-316, 2004.
Atkinson M, Budge H: Review of the NICE guidance on neonatal jaundice, Arch Dis Child Educ Pract Ed 96:136-140, 2011.
Bhutani VK, Stark AR, Lazzeroni LC, et al: Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy, J Pediatr 162:477-482, 2013.
Chang PF, Lin YC, Liu K, et al: Risk of hyperbilirubinemia in breast-fed infants, J Pediatr 159:561-565, 2011.
Flaherman VJ, Kuzniewicz MW, Escobar GJ, et al: Total serum bilirubin exchange transfusion thresholds in the setting of universal screening, J Pediatr 160:796-800, 2012.
Hegyi T, Kleinfeld A, Huber A, et al: Effects of soybean lipid infusion on unbound free fatty acids and unbound bilirubin in preterm infants, J Pediatr 184:45-50, 2017.
Keren R, Luam Z, Friedman S, et al: A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants, Pediatrics 121:e170-e179, 2008.
Kuzniewicz MW, Greene DN, Walsh EN, et al: Association between laboratory calibration of a serum bilirubin assay, neonatal bilirubin levels, and phototherapy use, JAMA Pediatr 170:557-561, 2016.
McGillivray A, Polverino J, Badawi N, Evans N: Prospective surveillance of extreme neonatal hyperbilirubinemia in Australia, J Pediatr 168:82-87, 2016.
Nagar G, Vandermeer B, Campbell S, et al: Reliability of transcutaneous bilirubin devices in preterm infants: a systematic review, Pediatrics 132:871-881, 2013.
Olusanya BO, Teeple S, Kassebaum NJ: The contribution of neonatal jaundice to global child mortality: findings from the GBD 2016 study, Pediatrics 141(2):e20171471, 2017.
Togawa T, Mizuochi T, Sugiura T, et al: Clinical, pathologic, and genetic features of neonatal Dubin-johnson syndrome: a multicenter study in Japan, J Pediatr 196:161-167, 2018.
US Preventive Services Task Force: Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: USPSTF recommendation statement, Pediatrics 124:1172-1177, 2009.
Vandborg PK, Hansen BM, Greisen G, et al: Follow up of neonates with total serum bilirubin levels >25 mg/dL: a Danish population-based study, Pediatrics 130:61-66, 2012.
Watchko JF, Tiribelli C: Bilirubin-induced neurologic damage-mechanisms and management approaches, N Engl J Med 369:2021-2028, 2013.
Yanagi T, Nakahara S, Maruo Y: Bilirubin uridine diphosphate-glucuronosyltransferase polymorphism as a risk factor for prolonged hyperbilirubinemia in Japanese preterm infants, J Pediatr 190:159-162, 2017.
Amin SB, Saluja S, Saili A, et al: Chronic auditory toxicity in late preterm and term infants with significant hyperbilirubinemia, Pediatrics 140(4):e20164009, 2017.
Ip S, Chung M, Trikalinos T, et al: Screening for bilirubin encephalopathy, Evidence synthesis no 72, AHRQ pub no 10-05140-EF-1, Rockville, Md, 2009, Agency for Healthcare Research and Quality.
Malwade US, Jardine LA: Home- versus hospital-based phototherapy for the treatment of non-haemolytic jaundice in infants at more than 37 weeks' gestation, Cochrane Database Sys Rev (6):CD010212, 2014.
Newman TB, Liljestrand P, Jeremy RJ, et al: Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more, N Engl J Med 354:1889-1900, 2006.
Newman TB, Wickremasinghe AC, Walsh EM, et al: Retrospective cohort study of phototherapy and childhood cancer in northern California, Pediatrics 137(6):e20151354, 2016.
Okwundu CI, Okoromah CAN, Shah PS: Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants (review), Evid-Based Child Health 8(1):204-249, 2013.
Slusher TM, et al: A randomized trial of phototherapy with filtered sunlight in African neonates, N Engl J Med 373:1115-1124, 2015.
Wickremasinghe AC, et al: Risk of sensorineural hearing loss and bilirubin exchange transfusion thresholds, Pediatrics 136:505-512, 2015.
Wickremasinghe AC, Kuzniewicz MW, Grimes BA, et al: Neonatal phototherapy and infantile cancer, Pediatrics 137(6):e20151353, 2016.
Wu YW, Kuzniewicz MW, Croen L, et al: Risk of autism associated with hyperbilirubinemia and phototherapy, Pediatrics 138(4):e20161813, 2016.
Aher S, Ohlsson A: Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants, Cochrane Database Syst Rev (4):CD004868, 2014.
Andersson O, Hellstrom-Westas L, Andersson D, et al: Effect of delayed versus early umbilical cord clamping on neonatal outcomes and iron status at 4 months: a randomized controlled trial, BMJ 343:d7157, 2011.
Bizzarro MJ, Colson E, Ehrenkranz RA: Differential diagnosis and management of anemia in the newborn, PediatrClin North Am 51:1087-1107, 2004.
Bromiker R, Kasinetz Y, Kaplan M, et al: Sucking improvement following blood transfusion for anemia of prematurity, Arch PediatrAdolesc Med 166:897-901, 2012.
Christensen RD, Henry E: Hereditary spherocytosis on neonates with hyperbilirubinemia, Pediatrics 125:120-125, 2010.
Christensen RD, Jopling HE, Jopling J, Wiedmeir SE: The CBC: reference ranges for neonates, SeminPerinatol 33(1):3-11, 2009.
Ferguson D, Hebert PC, Hogan DL, et al: Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants, JAMA 308:1443-1450, 2012.
Finn PH, Halvosen S: Regulation of erythropoiesis in the fetus and newborn, Arch Dis Child 47(255):683-687, 1972.
Jopling J, Henry E, Wiedmeir SE, Christensen RD: Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period: data from a multihospital health care system, Pediatrics 123(2):e333-e337, 2009.
Katheria AC, Truong G, Cousins L, et al: Umbilical cord milking versus delayed cord clamping in preterm infants, Pediatrics 136(1):61-69, 2015.
Kc A, Rana N, Malqvist M, et al: Effects of delayed umbilical cord clamping vs early clamping on anemia in infants at 8 and 12 months: a randomized clinical trial, JAMA Pediatr 171(3):264-270, 2017.
Koelewijn JM, de Haas M, Vrijkotte TG, et al: One single dose of 200 ^g of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy, Transfusion 48:1721, 2008.
Ohls RK, Roohi M, Peceny HM, et al: A randomized, masked study of weekly erythropoietin dosing in preterm infants, J Pediatr 160:790-795, 2012.
Ohlsson A, Aher SM: Early erythropoiesis-stimulating agents in preterm and/or low birth weight infants, Cochrane Database Syst Rev (11):CD004863, 2017.
Rabe H, Reynolds G, Diaz-Rossello J: Early versus delayed umbilical cord clamping in preterm infants, Cochrane Database Syst Rev (4):CD003248, 2004.
Raju TNK, Singhal N: Optimal timing for clamping the umbilical cord after birth, ClinPerinatol 39:889-900, 2012.
Raju TNK: Timing of umbilical cord clamping after birth for optimizing placental transfusion, CurrOpinPediatr 25:180-187, 2013.
Steiner LA, Gallagher PG: Erythrocyte disorders in the perinatal period, SeminPerinatol 31(4):254-261, 2007.
Warwood TL, Lambert DK, Henry E, et al: Very low birth weight infants qualifying for a ‘late' erythrocyte transfusion: does giving darbepoetin along with the transfusion counteract the transfusion's erythropoietic suppression?, J Perinatol (Suppl 1):S17-S21, 2011.
Whyte R, Kirpalani H: Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants, Corhrane Database Syst Rev (11):CD00512, 2011.
Wildness JA: Pathophysiology of anemia during the neonatal period, including anemia of prematurity, Neoreviews 9(11):e520, 2008.
Corvaglia L, Legnani E, Galletti S, et al: Intravenous immunoglobulin to treat neonatal alloimmunehaemolytic disease, J Matern Fetal Neonatal Med 25:2782-2785, 2012.
Fasano RM: Hemolytic disease of the fetus and newborn in the molecular era, Semin Fetal Neonatal Med 21:28-34, 2016.
Hendrickson JE, Delaney M: Hemolytic disease of the fetus and newborn: modern practice and future investigations, Transfus Med Rev 30:159-164, 2016.
Oepkes D, Seaward PG, Vandenbussche FP, et al: Doppler ultrasonography versus amniocentesis to predict fetal anemia, N Engl J Med 355:156-164, 2006.
Rath ME, Smits-Wintjens VE, Walther FJ, Lopriore E: Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization, Early Hum Dev 87:583-588, 2011.
Sandler SG, Flegel WA, Westhoff CM, et al: It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group, Transfusion 55:680-689, 2015.
Smits-Wintjens VE, Rath ME, van Zwet EW, et al: Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease, Neonatology 103:141-147, 2013.
McDonald SJ, Middleton P, Dowswell T, Morris PS: Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes, Evid Based Child Health 9:303, 2014.
Mimouni FB, Merlob P, Dollberg S, et al: Neonatal polycythaemia: critical review and a consensus statement of the Israeli Neonatology Association, ActaPaediatr 100:1290-1296, 2011.
Ozek E, Soll R, Schimmel MS: Partial exchange transfusion to prevent neurodevel- opmental disability in infants with polycythemia, Cochrane Database Syst Rev (1):CD005089, 2010.
Pappas A, Delaney-Black V: Differential diagnosis and management of polycythemia, PediatrClin North Am 51:1063-1086, 2004.
American Academy of Pediatrics Committee on Fetus and Newborn: Controversies concerning vitamin K and the newborn, Pediatrics 112:191-192, 2003.
Andrew M, Vegh P, Johnston M, et al: Maturation of the hemostatic system during childhood, Blood 80(8):1998-2005, 1992.
Kulkarni R, Presley RJ, Lusher JM, et al: Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System, Haemophilia 23(2):207-214, 2017.
Puckett RM, Offringa M: Prophylactic vitamin K for vitamin K deficiency bleeding in neonates, Cochrane Database Syst Rev (4):CD002776, 2000.
Rech MA, Wittekindt L, Friedman SD, et al: Prothrombin complex concentrate for intracerebral hemorrhage secondary to vitamin K deficiency bleeding in a 6-week-old child, J Pediatr 167(6):1443-1444, 2015.
Sallmon H, Sola-Visner M: Clinical and research issues in neonatal anemia and thrombocytopenia, CurrOpinPediatr 24:16-22, 2012.
Schulte R, Jordan LC, Morad A, et al: Rise in late onset vitamin K deficiency bleeding in young infants because of omission or refusal of prophylaxis at birth, PediatrNeurol 50:564-568, 2014.
Simak J, Holada K, Janota J, Stranak Z: Surface expression of major membrane glycoproteins on resting and TRAP-activated neonatal platelets, Pediatr Res 46(4):445-449, 1999.
Van Hasselt PM, de Koning TJ, Kvist N, et al: Prevention of vitamin K deficiency bleeding in breastfed infants: lessons from the Dutch and Danish biliary atresia registries, Pediatrics 121:e857-e863, 2008.
Steurer MA, Peyvandi S, Baer RJ, et al: Epidemiology of live born infants with nonimmune hydrops fetalis: insights from a population-based dataset, J Pediatr 187:182-188, 2017.
Bagade S, Khanna G: Imaging of omphalomesenteric duct remnants and related pathologies in children, CurrProbDiagnRadiol 44:246-255, 2015.
Hosono S, Hine K, Nagano N, et al: Residual blood volume in the umbilical cord of extremely premature infants, PediatrInt 57:68-71, 2015.
Imdad A, Bautista RM, Senen KA, et al: Umbilical cord antiseptics for preventing sepsis and death among newborns, Cochrane Database Syst Rev (5):CD008635, 2013.
Karumbi J, Mulaku M, Aluvaala J, et al: Topical umbilical cord care for prevention of infection and neonatal mortality, Pediatr Infect Dis J 32:78-83, 2013.
Kieliszak CR, Pollinger TH, Tollefson MM, Griffin JR: Umbilical and periumbilical dermatoses, J Am AcadDermatol 72:1066-1073, 2015.
McDonald S, Middleton P, Dowswell T, Morris PS: Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes, Cochrane Database Syst Rev (12):CD004074, 2015.
Omphalocele. In Bianchi DW, Crombleholme TM, D'Alton ME, editors: Fetology: diagnosis and management of the fetal patient, New York, 2000, McGraw-Hill Medical Publishing, pp 483-491.
Rabe H, Diaz-Rossello JL, Duley L, Dowswell T: Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes, Cochrane Database Syst Rev (8):CD003248, 2012.
Single umbilical artery. In Bianchi DW, Crombleholme TM, D'Alton ME, editors: Fetology: diagnosis and management of the fetal patient, New York, 2000, McGraw-Hill Medical Publishing, pp 827-831.
Sinha A, Sazawal S, Pradhan A, et al: Chlorhexidine skin or cord care for prevention of mortality and infections in neonates, Cochrane Database Syst Rev (3):CD007835, 2015.
Abdel-Latif ME, Pinner J, Clews S, et al: Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers, Pediatrics 117(6):e1163-e1169, 2006.
American Academy of Pediatrics Committee on Drugs: Neonatal drug withdrawal, Pediatrics 101(6):1079-1088, 1998.
American Society of Addiction Medicine: ACOG committee opinion no 524: opioid abuse, dependence, and addiction in pregnancy, Obstet Gynecol 119(5):1070-1076, 2012.
Asti L, Magers JS, Keels E, et al: A quality improvement project to reduce length of stay for neonatal abstinence syndrome, Pediatrics 135(6):e1494-e1500, 2015.
Bateman BT, Hernandez-Diaz S, Rathmell JP, et al: Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States, Anesthesiology 120(5):1216-1224, 2014.
Behnke M, Smith VC: Prenatal substance abuse: short- and long-term effects on the exposed fetus, Pediatrics 131(3):e1009-e1024, 2013.
Choo RE, Huestis MA, Schroeder JR, et al: Neonatal abstinence syndrome in methadone- exposed infants is altered by level of prenatal tobacco exposure, Drug Alcohol Depend 75(3):253-260, 2004.
Cleveland LM, Bonugli R: Experiences of mothers of infants with neonatal abstinence syndrome in the neonatal intensive care unit, J Obstet Gynecol Neonatal Nurs 43(3):318-329, 2014.
Desai RJ, Huybrechts KF, Hernandez-Diaz S, et al: Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study, BMJ 350:h2102, 2015.
Fraser JA, Barnes M, Biggs HC, Kain VJ: Caring, chaos and the vulnerable family: experiences in caring for newborns of drug-dependent parents, Int J Nurs Stud 44(8):1363-1370, 2007.
Frederick DL: Toxicology testing in alternative specimen matrices, Clin Lab Med 32(3):467-492, 2012.
Grossman MR, Berkwitt AK, Osborn RR, et al: An initiative to improve the quality of care of infants with neonatal abstinence syndrome, Pediatrics 139(6):e20163360, 2017.
Grossman MR, Lipshaw MJ, Osborn RR, Berkwitt AK: A novel approach to assessing infants with neonatal abstinence syndrome, Hosp Pediatr 8(1):1-6, 2018.
Hall ES, Isemann BT, Wexelblatt SL, et al: A cohort comparison of buprenorphine versus methadone treatment for neonatal abstinence syndrome, J Pediatr 170:39-44, e31, 2016.
Hall ES, Meinzen-Derr J, Wexelblatt SL: Cohort analysis of a pharmacokinetic-modeled methadone weaning optimization for neonatal abstinence syndrome, J Pediatr 167(6):1221-1225, e1221, 2015.
Hall ES, Wexelblatt SL, Crowley M, et al: A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome, Pediatrics 134(2):e527-e534, 2014.
Hall ES, Wexelblatt SL, Crowley M, et al: Implementation of a neonatal abstinence syndrome weaning protocol: a multicenter cohort study, Pediatrics 136(4):e803-e810, 2015.
Holmes AV, Atwood EC, Whalen B, et al: Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost, Pediatrics 137(6):2016.
Hudak ML, Tan RC: Neonatal drug withdrawal, Pediatrics 129(2):e540-e560, 2012.
Huybrechts KF, Bateman BT, Desai RJ, et al: Risk of neonatal drug withdrawl after intrauterine co-exposure to opioids and psychotropic medications: cohort study, BMJ 358:j3326, 2017.
Jones HE, Kaltenbach K, Heil SH, et al: Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?, J Matern Fetal Neonatal Med 25(7):1197-1201, 2012.
Kandall SR, Gartner LM: Late presentation of drug withdrawal symptoms in newborns, Am J Dis Child 127(1):58-61, 1974.
Kenan K, Mack K, Paulozzi L: Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000-2010, Open Med 6(2):e41-e47, 2012.
Ko JY, Wolicki S, Barfield WD, et al: CDC grand rounds: public health strategies to prevent neonatal abstinence syndrome, MMWR Morb Mortal Wkly Rep 66(9):242-245, 2017.
Kraft WK, Gibson E, Dysart K, et al: Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial, Pediatrics 122(3):e601-e607, 2008.
Lester BM, Tronick EZ, Brazelton TB: The neonatal intensive care unit network neurobehavioral scale procedures, Pediatrics 113(3 Pt 2):641-667, 2004.
Managing chronic pain in adults with or in recovery from substance use disorders. Treatment improvement protocol (TIP) series, No. 54. Center for substance abuse treatment, Rockville, MD, 2012, Substance Abuse and Mental Health Services Administration (US). Report No: (SMA) 12-4671.
McGlone L, Hamilton R, McCulloch DL, et al: Neonatal visual evoked potentials in infants born to mothers prescribed methadone, Pediatrics 131(3):e857-e863, 2013.
McQueen K, Murphy-Oikonen J: Neonatal abstinence syndrome, N Engl J Med 375(25):2468-2479, 2016.
O'Donnell M, Nassar N, Leonard H, et al: Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement, Pediatrics 123(4):e614-e621, 2009.
Oei JL, Melhuish E, Uebel H, et al: Neonatal abstinence syndrome and high school performance, Pediatrics 139(2):e20162651, 2017.
Oro AS, Dixon SD: Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates, J Pediatr 111(4):571-578, 1987.
Osborn DA, Jeffery HE, Cole MJ: Opiate treatment for opiate withdrawal in newborn infants, Cochrane Database Syst Rev (10):CD002059, 2010.
Patrick SW, Davis MM, Lehmann CU, Cooper WO: Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012, J Perinatol 35(8):650-655, 2015.
Patrick SW, Dudley J, Martin PR, et al: Prescription opioid epidemic and infant outcomes, Pediatrics 135(5):842-850, 2015.
Patrick SW, Kaplan HC, Passarella M, et al: Variation in treatment of neonatal abstinence syndrome in US children's hospitals, 2004-2011, J Perinatol 34(11):867-872, 2014.
Patrick SW, Schumacher RE, Benneyworth BD, et al: Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009, JAMA 307(18):1934-1940, 2012.
Tolia VN, Patrick SW, Bennett MM, et al: Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs, N Engl J Med 372(22):2118-2126, 2015.
Wachman EM, Hayes MJ, Brown MS, et al: Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome, JAMA 309(17):1821-1827, 2013.
Wexelblatt SL, Ward LP, Torok K, et al: Universal maternal drug testing in a high- prevalence region of prescription opiate abuse, J Pediatr 166(3):582-586, 2015.
Whelan PJ, Remski K: Buprenorphine vs methadone treatment: a review of evidence in both developed and developing worlds, J Neurosci Rural Pract 3(1):45-50, 2012.
Wiles JR, Isemann B, Ward LP, et al: Current management of neonatal abstinence syndrome secondary to intrauterine opioid exposure, J Pediatr 165(3):440-446, 2014.
Balkowiec-Iskra E, Mirowska-Guzel DM, Wielgos M: Effect of antidepressants use in pregnancy on foetus development and adverse effects in newborns, Ginekol Pol 88(1):36-42, 2017.
Gavin NI, Gaynes BN, Lohr KN, et al: Perinatal depression: a systematic review of prevalence and incidence, Obstet Gynecol 105(5 Pt 1):1071-1083, 2005.
Grigoriadis S, Vonder Porten EH, Mamisashvili L, et al: Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis, BMJ 348:f6932, 2014.
Holland J, Brown R: Neonatal venlafaxine discontinuation syndrome: a mini-review, Eur J Paediatr Neurol 21:264-268, 2017.
Kieviet N, Dolman KM, Honig A: The use of psychotropic medication during pregnancy: how about the newborn?, Neuropsychiatr Dis Treat 9:1257-1266, 2013.
Lorenzo L, Einarson A: Antidepressant use in pregnancy: an evaluation of adverse outcomes excluding malformations, Isr J Psychiatry Relat Sci 51:94-97, 2014.
Norby U, Forsberg L, Wide K, et al: Neonatal morbidity after maternal use of antidepressant drugs during pregnancy, Pediatrics 138(5):e20161124, 2016.
Orsolini L, Bellantuono C: Serotonin reuptake inhibitors and breastfeeding: a systematic review, Hum Psychopharmacol 30:4-20, 2015.
Bax AC, Geurts CD, Balachova TN: Improving recognition of children affected by prenatal alcohol exposure: detection of exposure in pediatric care, Curr Dev Disord Rep 2(3):165-174, 2015.
Bertrand J: Interventions for children with fetal alcohol spectrum disorders (FASDs): overview of findings for five innovative research projects, Res Dev Disabil 30(5):986-1006, 2009.
Centers for Disease Control and Prevention: Fetal alcohol spectrum disorders (FASDs): alcohol use in pregnancy, 2014. http://www.cdc.gov/ncbddd/fasd/alcohol-use.html.
Chasnoff IJ, Wells AM, King L: Misdiagnosis and missed diagnoses in foster and adopted children with prenatal alcohol exposure, Pediatrics 135(2):264-270, 2015.
Cook JL, Green CR, Lilley CM, et al: Fetal alcohol spectrum disorder: a guideline for diagnosis across the lifespan, CMAJ 188(3):191—197, 2016.
Fox DJ, Pettygrove S, Cunniff C, et al: Fetal alcohol syndrome among children aged 7-9 years—Arizona, Colorado, and New York, 2010, MMWR Morb Mortal Wkly Rep 64(3):54-57, 2015.
Hoyme HE, Kalberg WO, Elliott AJ, et al: Updated clinical guidelines for diagnosing fetal alcohol spectrum disorders, Pediatrics 138(2):2016.
Lange S, Shield K, Koren G, et al: A comparison of the prevalence of prenatal alcohol exposure obtained via maternal self-reports versus meconium testing: a systematic literature review and meta-analysis, BMC Pregnancy Childbirth 14(1):127, 2014.
May PA, Baete A, Russo J, et al: Prevalence and characteristics of fetal alcohol spectrum disorders, Pediatrics 134(5):855-866, 2014.
May PA, Gossage JP: Estimating the prevalence of fetal alcohol syndrome. a summary, Alcohol Res Health 25(3):159-167, 2001.
Petrenko CL, Tahir N, Mahoney EC, Chin NP: A qualitative assessment of program characteristics for preventing secondary conditions in individuals with fetal alcohol spectrum disorders, J Popul Ther Clin Pharmacol 21(2):e246, 2014.
Williams JF, Smith VC: Fetal alcohol spectrum disorders, Pediatrics 136(5):e1395-e1406, 2015.
American Academy of Pediatrics, Rose SR; Section on Endocrinology and Committee on Genetics, American Thyroid Association, Brown RS; Public Health Committee, Lawson Wilkins Pediatric Endocrine Society, Foley T, et al: Update of newborn screening and therapy for congenital hypothyroidism, Pediatrics 117:2290-2303, 2006.
Fort P, Lifshitz F, Bellisario R, et al: Abnormalities of thyroid function in infants with Down syndrome, J Pediatr 104(4):545-549, 1984.
Gyurkovits Z, Maroti A, et al: Adrenal haemorrhage in term neonates: a retrospective study from the period 2001-2013, J Matern Fetal Neonatal Med 28(17):2062-2065, 2015.
Harris KB, Pass KA: Increase in congenital hypothyroidism in New York State and in the United States, Mol Genet Metab 91(3):268-277, 2007.
Shield JP: Neonatal diabetes, Horm Res 68(Suppl 5):32-36, 2007.
Van Trotsenburg AS, Vulsma T, et al: Lower neonatal screening thyroxine concentrations in Down syndrome newborns, J ClinEndocrinolMetab 88:1512-1515, 2003.
Adamkin DH: Postnatal glucose homeostasis in late-preterm and term infants, Pediatrics 127:575-579, 2011.
Alsweiler JM, Harding JE, Bloomfield FH: Tight glycemic control with insulin in hyperglycemic preterm babies: a randomized controlled trial, Pediatrics 129:639-647, 2012.
Bietsy LM, Egan AM, Dunne F, et al: Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants, Cochrane Database Syst Rev (1):CD012910, 2018.
Crowther CA, Hiller JE, Moss JR, et al: Australian carbohydrate intolerance study in pregnant women (ACHOIS) trial group: effect of treatment of gestational diabetes mellitus on pregnancy outcomes, N Engl J Med 352:2477-2486, 2005.
Feig DS, Donovan LE, Corcoy R, et al: Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicenter international randomized controlled trial, Lancet 390:2347-2358, 2017.
Forster DA, Moorhead AM, Jacobs SE, et al: Advising women with diabetes in pregnancy to express breast milk in late pregnancy (diabetes and antenatal milk expressing [DAME]): a multicenter, unblinded, randomized controlled trial, Lancet 389:2204-2213, 2017.
Harris DL, Weston PJ, Harding JE: Incidence of neonatal hypoglycemia in babies identified as at risk, J Pediatr 161:787-791, 2012.
Hegarty JE, Harding JE, Gamble GD, et al: Prophylactic oral dextrose gel for newborn babies at risk of neonatal hypoglycaemia: a randomized controlled dose-finding trial (the Pre-hPOD study), PLoS Med 13(10):e1002155, 2016.
Ludvigsson JF, Neovius M, Soderling J, et al: Periconceptionglycaemic control in women with type 1 diabetes and risk of major birth defects: population-based cohort study in Sweden, BMJ 362:k2638, 2018.
Mathiesen ER, Ringholm L, Damm P: Stillbirth in diabetic pregnancies, Best Pract Res ClinObstetGynaecol 25:105-111, 2011.
Nold JL, Georgieff MK: Infants of diabetic mothers, PediatrClin North Am 51:619-637, 2004.
Rozance PJ, Hay WW Jr: Neonatal hypoglycemia—answers, but more questions, J Pediatr 161:775-776, 2012.
Thornton PS, Stanley CA, et al: Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children, J Pediatr 167:238-245, 2015.
Tin W, Brunskill G, Kelly T, et al: 15-year follow-up of recurrent “hypoglycemia” in preterm infants, Pediatrics 130:e1497-e1503, 2012.
Weston PJ, Harris DL, Battin M, et al: Oral dextrose gel for the treatment of hypoglycaemia in newborn infants, Cochrane Database Syst Rev (5):CD011027, 2016.
Ang ES Jr, Gluncic V, Duque A, et al: Prenatal exposure to ultrasound waves impacts neuronal migration in mice, Proc Natl Acad Sci USA 103:12903-12910, 2006.
Arth AC, Tinker SC, Simeone RM, et al: Inpatient hospitalization costs associated with birth defects among person of all ages—United States, 2013, MMWR Morb Mortal Wkly Rep 66(2):41-46, 2017.
Bamshad MJ, Ng SB, Bigham AW, et al: Exome sequencing as a tool for mendelian disease gene discovery, Nat Rev Genet 12:745-755, 2011.
Beaulieu CL, Majewski J, Schwartzentruber J, et al: FORGE Canada consortium: outcomes of a 2-year national rare-disease gene-discovery project, Am J Hum Genet 94:809-817, 2014.
Berry RJ, Buehler JW, Strauss LT, et al: Birth weight-specific infant mortality due to congenital anomalies, 1960 and 1980, Public Health Rep 102:171-181, 1987.
Biesecker LG, Green RC: Diagnostic clinical genome and exome sequencing, N Engl J Med 370:2418-2425, 2014.
Boyle RJ: Effects of certain prenatal drugs on the fetus and newborn, Pediatr Rev 23:17-24, 2002.
Chen Y, Liu Z, Chen J, et al: The genetic landscape and clinical implications of vertebral anomalies in VACTERL association, J Med Genet 53:431-437, 2016.
Cohen MM Jr: An introduction to sonic hedgehog signaling. In Epstein CJ, Erickson RP, Wynshaw-Boris A, editors: Inborn errors of development: the molecular basis of clinical disorders of morphogenesis, New York, 2004, Oxford University Press.
Cooper WO, Hernandez-Diaz S, Arbogast PG, et al: Major congenital malformations after first-trimester exposure to ACE inhibitors, N Engl J Med 354:2443-2451, 2006.
Epstein CJ: Human malformations and their genetic basis. In Epstein CJ, Erickson RP, Wynshaw-Boris A, editors: Inborn errors of development: the molecular basis of clinical disorders of morphogenesis, New York, 2004, Oxford University Press.
Epstein CJ: The new dysmorphology: application of insights from basic developmental biology to the understanding of human birth defects, Proc Natl Acad Sci USA 92:8566-8573, 1995.
Gleeson JG: LIS1 and DCX and classical lissencephaly. In Epstein CJ, Erickson RP, Wynshaw-Boris A, editors: Inborn errors of development: the molecular basis of clinical disorders of morphogenesis, New York, 2004, Oxford University Press.
Hall JG, Froster-Iskenius UG, Allanson JE: Handbook of normal physical measurements, New York, 1989, Oxford Medical Publications.
Hassold TJ, Patterson D: Down syndrome: a promising future together, New York, 1999, Wiley-Liss.
Hellmund A, Berg C, Geipel A, et al: Prenatal diagnosis of fetal akinesia deformation sequence (FADS): a study of 79 consecutive cases, Arch Gynecol Obstet 294(4):697-707, 2016.
Ho KS, Scott MP: Sonic hedgehog in the nervous system: functions, modifications and mechanisms, Curr Opin Neurobiol 12:57-63, 2002.
Hoekelman RA, Pless IB: Decline in mortality among young Americans during the 20th century: prospects for reaching national mortality reduction goals for 1990, Pediatrics 82:582-595, 1988.
Holmes LB: Inborn errors of morphogenesis: a review of localized hereditary malformations, N Engl J Med 291:763-773, 1974.
Irons M: DHCR7 and the Smith-lemli-opitz (RSH) syndrome. In Epstein CJ, Erickson
RP, Wynshaw-Boris A, editors: Inborn errors of development: the molecular basis of clinical disorders of morphogenesis, New York, 2004, Oxford University Press.
Jones KL: Smith's recognizable patterns of human malformation, ed 6, Philadelphia, 2005, Saunders.
Kingston HM, et al: Genetic assessment and pedigree analysis. In Rimoin DL, Connor JM, Pyeritz RE, editors: Emery and Rimoin's principles and practice of medical genetics, ed 4, New York, 2002, Churchill Livingstone.
Lee H, Deignan JL, Dorrani N, et al: Clinical exome sequencing for genetic identification of rare mendelian disorders, JAMA 312:1880-1887, 2014.
Lu X, Shaw CA, Patel A, et al: Clinical implementation of chromosomal microarray analysis: summary of 2513 postnatal cases, PLoS ONE 2:e327, 2007.
Lupski JR: Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits, Trends Genet 14:417-422, 1998.
Mitchell LE, Adzick NS, Melchionne J, et al: Spina bifida, Lancet 364:1885-1895, 2004. Miyamo A, Weinmaster G: Introduction to notch signaling. In Epstein CJ, Erickson RP, Wynshaw-Boris A, editors: Inborn errors of development: the molecular basis of clinical disorders of morphogenesis, New York, 2004, Oxford University Press.
Mulliken JB: The craniofacial surgeon as amateur geneticist, J Craniofac Surg 13:3-17, 2002.
Oskarsdottir S, Persson C, Eriksson BO, et al: Presenting phenotype in 100 children with 22q11 deletion syndrome, Eur J Pediatr 164:146-153, 2005.
Park SM, Mathur R, Smith GCS: Congenital anomalies after treatment for infertility, BMJ 333:665-666, 2006.
Penton AL, Leonard LD, Spinner NB: Notch signaling in human development and disease, Semin Cell Dev Biol 23(4):450-457, 2012.
Petrij F, Breuning MH, Hennekam RCM, et al: CBP and the Rubinstein-Taybi syndrome. In Epstein CJ, Erickson RP, Wynshaw-Boris A, editors: Inborn errors of development: the molecular basis of clinical disorders of morphogenesis, New York, 2004, Oxford University Press.
Plunkett KS, Simpson JL: A general approach to genetic counseling, Obstet Gynecol Clin North Am 29:265-276, 2002.
Quinlan RJ, Tobin JL, Beales PL: Modeling ciliopathies: primary cilia in development and disease, Curr Top Dev Biol 84:249-310, 2008.
Rauch A, Hoyer J, Guth S, et al: Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation, Am J Med Genet A 140:2063-2074, 2006.
Rimoin DL, Connor JM, Pyeritz RE, editors: Emery and Rimoin's principles and practice of medical genetics, ed 4, New York, 2002, Churchill Livingstone.
Salman M, Jhanwar SC, Ostrer H: Will the new cytogenetics replace the old cytogenetics?, Clin Genet 66:265-275, 2004.
Sharp AJ, Locke DP, McGrath SD, et al: Segmental duplications and copy-number variation in the human genome, Am J Hum Genet 77:78-88, 2005.
Soden SE, Saunders CJ, Willig LK, et al: Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders, Sci Transl Med 6:265, 2014.
Taylor JC, Martin HC, Lise S, et al: Factors influencing success of clinical genome sequencing across a broad spectrum of disorders, Nat Genet 47:717-726, 2015.
Turnpenny PD, Kusumi K: DLL3 and spondylocostal dysostosis. In Epstein CJ, Erickson
RP, Wynshaw-Boris A, editors: Inborn errors of development: the molecular basis of clinical disorders of morphogenesis, New York, 2004, Oxford University Press.
Vander Heiden MG: Metabolism and congenital malformations: NAD's effects on development, N Engl J Med 377(6):509-511, 2017.
Villavicencio EH, Walterhouse DO, Iannaccone PM: The sonic hedgehog-patched-GLI pathway in human development and disease, Am J Hum Genet 67:1047-1054, 2000.
Viswanathan M, Treiman KA, Kish-Doto J, et al: Folic acid supplementation for the prevention of neural tube defects: an updated evidence report and systematic review for the US preventive services task force, JAMA 317(2):190-203, 2017.
Wagenstaller J, Spranger S, Lorenz-Depiereux B, et al: Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation, Am J Hum Genet 81:768-779, 2007.
Wilson GN: Genomics of human dysmorphogenesis, Am J Med Genet 42:187-196, 1992. Yagi H, Furutani Y, Hamada H, et al: Role of TBX1 in human del22q11.2 syndrome, Lancet 362:1366-1373, 2003.
Benitz WE, Wynn JL, Polin RA: Reappraisal of guidelines for management of neonates with suspected early-onset sepsis, J Pediatr 166(4):1070-1074, 2015.
Bizzarro MJ, Shabanova V, Baltimore RS, et al: Neonatal sepsis 2004-2013: the rise and fall of coagulase-negative staphylococci, J Pediatr 166:1193-1199, 2015.
Bowen A, Wiesenfeld HC, Kloesz JL, et al: Cronobacter sakazakii infection associated with feeding extrinsically contaminated expressed human milk to a premature infant—Pennsylvania, 2016, MMWR 66(28):761-762, 2017.
Buser GL, Mato S, Zhang AY, et al: Late-onset infant group B streptococcus infection associated with maternal consumption of capsules containing dehydrated placenta—Oregon, 2016, MMWR 66(25):677-678, 2017.
Carola D, Vasconcellos M, Sloane A, et al: Utility of early-onset sepsis risk calculator for neonates born to mothers with chorioamnionitis, J Pediatr 195:48-52, 2018.
Curfman AL, Glissmeyer EW, Ahmad FA, et al: Initial presentation of neonatal herpes simplex virus infection, J Pediatr 172:121-126, 2016.
Esparcia O, Montemayor M, Ginovart G, et al: Diagnostic accuracy of a 16s ribosomal DNA gene-based molecular technique (RT-PCR, microarray, and sequencing) for bacterial meningitis, early-onset neonatal sepsis, and spontaneous bacterial peritonitis, Diag Microbiol Infect Dis 69:153-160, 2011.
Fraser N, Davies BW, Cusack J: Neonatal omphalitis: a review of its serious complications, Acta Paediatr 95:519-522, 2006.
Granseth G, Bhattarai R, Sylvester T, et al: Two cases of legionnaires' disease in newborns after water births—Arizona, 2016, MMWR Morb Mortal Wkly Rep 66:590-591, 2017.
Gras-Le Guen C, Caille A, Launay E, et al: Dry care versus antiseptics for umbilical cord care: a cluster randomized trial, Pediatrics 139(1):e20161857, 2017.
Grunebaum A, McCullough LB, Arabin B, et al: Underlying causes of neonatal deaths in term singleton pregnancies: home births versus hospital births in the United States, J Perinat Med 45(3):349-357, 2016.
Higgins RD, Saade G, Polin RA, et al: Evaluation and management of women and newborns with a maternal diagnosis of chorioammionitis: summary of a workshop, Obstet Gynecol 127(3):426-436, 2016.
Jan AI, Ramanathan R, Cayabyab RG: Chorioamnionitis and management of asymptomatic infants >35 weeks without empiric antibiotics, Pediatrics 140(1):e2016744, 2017.
Jefferies AL, Canadian Paediatric Society, Fetus and Newborn Committee: Position statement: management of term infants at increased risk for early-onset bacterial sepsis, Paediatr Child Health 22(4):223-228, 2017.
Kuzniewicz MW, Puopolo KM, Fischer A, et al: A quantitative, risk-based approach to the management of neonatal early-onset sepsis, J Pediatr 171(4):365-371, 2017.
Morris JM, Roberts CL, Bowen JR, et al: Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomized controlled trial, Lancet 387:444-452, 2016.
Mukhopadhyay S, Puopolo KM: Clinical and microbiologic characteristics of early- onset sepsis among very low birth weight infants: opportunities for antimicrobial stewardship, Pediatr Infect Dis J 36(5):477-481, 2017.
Pammi M, Flores A, Versalovic J, Leeflang MMG: Molecular assays for the diagnosis of sepsis in neonates, Cochrane Database Syst Rev (2):CD011926, 2017.
Pinniti SG, Angara R, Feja KN, et al: Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series, J Pediatr 161:134-138, 2012.
Polin RA, Committee on Fetus and Newborn: Management of neonates with suspected or proven early-onset bacterial sepsis, Pediatrics 129(5):1006-1015, 2012.
Puopolo KM, Mukhopadhyay S, Hansen NI, et al: Identification of extremely premature infants at low risk for early-onset sepsis, Pediatrics 140(5):e20170925, 2017.
Randis TM, Polin RA, Saade G: Chorioamnionitis: time for a new approach, Curr Opin Pediatr 29:159-164, 2017.
Sengupta M, Banerjee S, Banerjee P, Guchhait P: Outstanding prevalence of methicillin-resistant Staphylococcus aureus in neonatal omphalitis, J Clin Diagn Res 10(9):DM1-DM3, 2016.
Shah SS, Gallagher PG: Complications of conjunctivitis caused by pseudomonas aeruginosa in a newborn intensive care unit, Pediatr Infect Dis J 17(2):97-102, 1998.
Sinha A, Sazawal S, Pradhan A, et al: Chlorhexidine skin or cord care for prevention of mortality and infections in neonates, Cochrane Database Syst Rev (3):CD007935, 2015.
Stocker M, van Herk W, el Helou S, et al: Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicenter, randomized controlled trial (NeoPlns), Lancet 390:873-881, 2017.
Tibussek D, Sinclair A, Yau I, et al: Late-onset group B streptococcal meningitis has cerebrovascular complications, J Pediatr 166:1187-1192, 2015.
Tshefu A, Lokangaka A, Ngaima S, et al: Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomized, open-label, equivalence trial, Lancet 385:1767-1776, 2015.
Tshefu A, Lokangaka A, Ngaima S, et al: Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomized, open-label, equivalence trial, Lancet 385:1758-1766, 2015.
Botero-Calderon L, Benjamin DK Jr, Cohen-Wolkowiez M: Advances in the treatment of invasive neonatal candidiasis, Expert OpinPharmacother 16(7):1035-1048, 2015.
Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory Committee: Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/ APIC/IDSA Hand Hygiene Task Force, Am J Infect Control 30(8):S1-S46, 2002.
Civardi E, Tzialla C, Baldanti F, et al: Viral outbreaks in neonatal intensive care units: what we do not know, Am J Infect Control 41(10):854-856, 2013.
Ericson JE, Kaufman DA, Kicklighter SD, et al: Fluconazole prophylaxis for the prevention of candidiasis in premature infants: a meta-analysis using patient-level data, Clin Infect Dis 63(5):604-610, 2016.
Garland JS: Strategies to prevent ventilator-associated pneumonia in neonates, ClinPerinatol 37(3):629-643, 2010.
Grohskopf LA, Sinkowitz-Cochran RL, Garrett DO, et al: A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States, J Pediatr 140(4):432-438, 2002.
Hooven TA, Polin RA: Healthcare-associated infections in the hospitalized neonate: a review, Early Hum Dev 90: S4-S6, 2014.
Ista E, van der Hoven B, Kornelisse RF, et al: Effectiveness of insertion and maintenance bundles to prevent central-line-associated bloodstream infections in critically ill patients of all ages: a systematic review and meta-analysis, Lancet Infect Dis 16(6):724-734, 2016.
Larson EL, Quiros D, Lin SX: Dissemination of the CDC's Hand Hygiene Guideline and impact on infection rates, Am J Infect Control 35(10):666-675, 2007.
Legeay C, Bourigault C, Lepelletier D, Zahar JR: Prevention of healthcare-associated infections in neonates: room for improvement, J Hosp Infect 89(4):319-323, 2015.
Ortegon L, Puentes-Herrera M, Corrales IF, Cortes JA: Colonization and infection in the newborn infant: does chlorhexidine play a role in infection prevention?Arch ArgentPediatr 115(1):65-70, 2017.
Pierce R, Bryant K, Elward A, et al: Bacterial infections in neonates following mupirocin-based MRSA decolonization: a multicenter cohort study, Infect Control Hosp Epidemiol 38(8):930-936, 2017.
Polin RA, Denson S, Brady MT: Epidemiology and diagnosis of health care-associated infections in the NICU, Pediatrics 129(4):e1104-e1109, 2012.
Ramasethu J: Prevention and treatment of neonatal nosocomial infections, Matern Health NeonatolPerinatol 3:5, 2017.
Stoll BJ, Hansen N, Fanaroff AA, et al: Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network, Pediatrics 110(2 Pt 1):285-291, 2002.
Tablan OC, Anderson LJ, Besser R, et al: Guidelines for preventing health-care- associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee, MMWR Recomm Rep 53(RR-3):1-36, 2004.
Taylor JE, McDonald SJ, Tan K: Prevention of central venous catheter-related infection in the neonatal unit: a literature review, J Matern Fetal Neonatal Med 28(10):1224-1230, 2015.
Waters V, Larson E, Wu F, et al: Molecular epidemiology of gram-negative bacilli from infected neonates and health care workers' hands in neonatal intensive care units, Clin Infect Dis 38(12):1682-1687, 2004.
Won SP, Chou HC, Hsieh WS, et al: Handwashing program for the prevention of nosocomial infections in a neonatal intensive care unit, Infect Control Hosp Epidemiol 25(9):742-746, 2004.
American Academy of Pediatrics: Syphilis. In Kimberlin DW, Brady MT, Jackson MA, Long SS, editors: Red book: 2018-2021 report of the committee on infectious diseases, ed 31, Itasca, IL, 2018, American Academy of Pediatrics, pp 773-788.
Bilavsky E, Pardo J, Attias J, et al: Clinical implications for children born with congenital cytomegalovirus infection following a negative amniocentesis, Clin Infect Dis 63:33-38, 2016.
Boppana SB, Ross SA, Fowler KB: Congenital cytomegalovirus infection: clinical outcome, Clin Infect Dis 57(Suppl 4):S178-S181, 2013.
Castillo SA, Pham AK, Dinulos JG: Cutaneous manifestations of systemic viral diseases in neonates: an update, CurrOpinPediatr 29:240-248, 2017.
Forner G, Abate D, Mengoli C, et al: High cytomegalovirus (CMV) DNAemia predicts CMV sequelae in asymptomatic congenitally infected newborns born to women with primary infection during pregnancy, J Infect Dis 212:67-71, 2015.
Goderis J, Keymeulen A, Smets K, et al: Hearing in children with congenital cytomegalovirus infection: results of a longitudinal study, J Pediatr 172:110-115, 2016.
Hebbal P, Russell BK, Akande T, et al: Disseminated congenital cytomegalovirus infection presenting as severe sepsis in a preterm neonate, J Pediatr 170:339, 2016.
Higgins RD, Saade G: Chorioamnionitis workshop participants: evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop, ObstetGynecol 127(3):426-436, 2016.
James SH, Kimberlin DW: Neonatal herpes simplex virus infection, Infect Dis Clin North Am 29:391-400, 2015.
Kimberlin DW, Jester PM, Sanchez PJ, et al: Valganciclovir for symptomatic congenital cytomegalovirus disease, N Engl J Med 372(10):933-943, 2015.
Lanzieri TM, Leung J, Caviness AC, et al: Long-term outcomes of children with symptomatic congenital cytomegalovirus disease, J Perinatol 37:875-880, 2017.
Lopez AS, Lanzieri TM, Claussen AH, et al: Intelligence and academic achievement with asymptomatic congenital cytomegalovirus infection, Pediatrics 140(5):e20171517, 2017.
Maldonado YA, Read JS: American Academy of pediatrics committee on infectious diseases: diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States, Pediatrics 139(2):e20163860, 2017.
Meaney-Delman D, Hills SL, Williams C, et al: Zika virus infection among U.S. pregnant travelers—August 2015-February 2016, MMWR 65(8):211-214, 2016.
Melo ASO, Aguiar RS, Amorim MM, et al: Congenital zika virus infection: beyond neonatal microcephaly, JAMA Neurol 73(12):1407-1416, 2016.
Moore CA, Staples JE, Dobyns WB, et al: Characterizing the pattern of anomalies in congenital zika syndrome for pediatric clinicians, JAMA Pediatr 171(3):288-295, 2017.
Neu N, Duchon J, Zachariah P: TORCH infections, ClinPerinatol 42:77-103, 2015.
Pasternak Y, Ziv L, Attias J, et al: Valganciclovir is beneficial in children with congenital cytomegalovirus and isolated hearing loss, J Pediatr 199:166-170, 2018.
Rawlinson WD, Boppana SB, Fowler KB, et al: Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy, Lancet Infect Dis 17:e177-e188, 2017.
Read JS: Committee on pediatric AIDS: diagnosis of HIV-1 infection in children younger than 18 months in the United States, Pediatrics 120(6):e1547-e1562, 2007.
Shah T, Luck S, Sharland M, et al: Fifteen-minute consultation: diagnosis and management of congenital CMV, Arch Dis Child EducPract Ed 101:232-235, 2016.
US Preventive Services Task Force: Screening for syphilis infection in pregnant women, February 2018.
Uda K, Sasaki Y, Shoji K, Miyairi I: Pulmonary calcification in a congenital cytomegalovirus infection, J Pediatr 190:286, 2017.
Труды отечественных авторов при подготовке статей по педиатрии для пользователей сайта - не использовались, так как их вы всегда можете найти в библиотеках.
